Assessment of flavonoid and fatty acid intake by chemical analysis of biomarkers and the duplicate diets by Vries, J.H.M., de
Assessment of flavonoid and fatty acid 
intake by chemical analysis of 
biomarkers and of duplicate diets 
Jeanne H.M. de Vries 
Promotoren: Dr. M.B. Katan 
Universitair hoofddocent Landbouwuniversiteit Wageningen 
Bijzonder hoogleraar in de voedingsleer van de mens 
Katholieke Universiteit Nijmegen 
Dr. W.A. van Staveren 
Bijzonder hoogleraar in de voeding van de oudere mens 
Landbouwuniversiteit Wageningen 
fM^ZO\ ^ ^ 
Assessment of flavonoid and fatty acid intake by 
chemical analysis of biomarkers and of duplicate diets 
Jeanne H.M. de Vries 
Proefschrift 
ter verkrijging van de graad van doctor 
op gezag van de rector magnificus 
van de Landbouwuniversiteit Wageningen, 
dr. CM. Karssen, 
in het openbaar te verdedigen 
op vrijdag 6 februari 1998 
des namiddags te vier uur in de Aula. 
^arz^f 
The research described in this thesis was financially supported by the Netherlands Heart 
Foundation (93.084), and the Foundation for Nutrition and Health Research. 
Financial support for the publication of this thesis by the Wageningen Agricultural 
University and the Netherlands Heart Foundation is gratefully acknowledged. 
Assessment of flavonoid and fatty acid intake by chemical analysis of biomarkers and of 
duplicate diets 
Jeanne H.M. de Vries 
ISBN 90-9011303-7 
Cover: Nel van Mierlo 
"Still life with wine, tea, and onion" 
Oss 1997 
Acrylic paint on board 55 x 42 cm 
Printing: Grafisch Bedrijf Ponsen & Looijen BV, Wageningen, The Netherlands 
1997 J.H.M. de Vries 
BIBLIOTHEEK 
LANDBOUWUNIVERSITETT 
WAGENINGEN 
^Mo?ZO^ , ^ 
Stellingen 
1. Gehaltes van flavonolen in plasma en urine zijn geschikte indicatoren om mensen 
met een lage en een hoge inneming van deze stoffen uit de voeding van elkaar te 
kunnen onderscheiden. Dit proefschrift. 
2. De bestaande voedselfrequentiemethodes zijn niet geschikt om de inneming van 
flavonoiden nauwkeurig vast te stellen. Mogelijke verbanden tussen de inneming van 
flavonoiden, vastgesteld met deze methodes, en het voorkomen van ziekten zijn 
daarom moeilijk aan te tonen. O.a. dit proefschrift. 
3. Rode wijn is geen goede bron van biobeschikbare flavonolen. Daarom kan inneming 
van deze stoffen met rode wijn de Franse paradox niet verklaren. 
Dit proefschrift. 
4. Het afwijzen van methodes voor het vaststellen van de voedselconsumptie alleen 
omdat ze te duur zijn, kan worden aangemerkt als zuinigheid die de wijsheid 
bedriegt. 
5. Biologische indicatoren zullen een belangrijke methode zijn voor het meten van de 
voedselconsumptie in een toekomstig Europa zonder grenzen, omdat ze objectieve 
vergelijking tussen studies in verschillende landen beter mogelijk maken dan andere 
voedselconsumptiemethodes. O.a. P. van 't Veer et al. Eur J Clin Nutr 1993; 47, 
Suppl2, S58-S63. 
6. Met uitzondering van de te onderzoeken voedingsstof heeft een goede proefvoeding 
niet alleen precies dezelfde samenstelling als de controlevoeding qua 
voedingsstoffen, maar ook qua voedingsmiddelen. 
7. Naarmate experimenten beter zijn opgezet wordt de kans op het optreden van het 
placebo-effect groter. 
8. Paramedici, zoals verloskundigen, fysiotherapeuten en dietisten, zouden verplicht 
moeten worden hun therapieen op een wetenschappelijk verantwoorde wijze te 
evalueren, omdat van sommige behandelingsmethodes schadelijke neveneffecten niet 
uit te sluiten zijn. 
9. Er zal meer aandacht moeten komen voor het ontwikkelen van aantrekkelijke 
gemakkelijk vol te houden dieten als therapie voor cholesterolverlaging, zodat het 
maximaal mogelijke effect kan worden gehaald. D. Kromhout, Diet-heart issues in 
a pharmacological era. Lancet 1996;348:S20-S22. 
10. Korter werken is beter voor de economie. 
Stellingen 
11. Pas als niet alleen 's morgens evenveel vaders als moeders hun kinderen naar school 
brengen, maar ook 's middags ouders van beide sexen evenredig vertegenwoordigd 
zijn voor het halen van de kinderen zal de emancipatie van mannen en vrouwen een 
feit zijn. 
12. Het belangrijkste resultaat verkregen bij het bereiken van het einde van de weg is 
het plezier waarmee je hem hebt afgelegd. 
Stellingen behorend bij het proefschrift 
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Abstract 
Assessment of flavonoid and fatty acid intake by chemical analysis of 
biomarkers and of duplicate diets 
PhD thesis, Jeanne H.M. de Vries, Division of Human Nutrition and Epidemiology, 
Wageningen Agricultural University, the Netherlands. February 6, 1998 
Dietary intake is important to investigate the relationship between diet and the occurrence 
of disease. However, it is difficult to assess the intake of nutrients such as flavonoids, minor 
fatty acids and plant sterols because the data on these nutrients in food composition tables 
are insufficient or because the bioavailability of these nutrients differs between foods. The 
results of studies investigating the relationship of these nutrients to disease are inconsistent, 
perhaps because of errors in the methods used to assess nutrient intake. The aim of this 
thesis was to evaluate physically and chemically based methods of measuring the intake of 
flavonoids, fatty acids, sterols and energy. 
We found differences of up to 80 mg per day in the intake of flavonols and flavones 
in subjects eating a variety of diets. The ratio of the within- to the between-subject variation 
in the intake of flavonols and flavones was lower than one, indicating that it is possible to 
study the relationship between flavonoid intake and disease. The food frequency 
questionnaire used in this study was suitable for classifying subjects by their flavonol 
intakes. 
We also found that the bioavailability of the flavonol quercetin differs between the 
major dietary sources. The bioavailability of quercetin from red wine was 75% of that from 
onions and from tea 50% of that from onions. Therefore, flavonols from red wine can 
probably not explain the lower incidence of coronary heart disease in France compared to 
other western countries. Concentrations of quercetin in plasma can be used as biomarkers 
to distinguish between subjects with a low and with a high flavonol intake. This is possible 
because of a relatively small variation of plasma quercetin and a linear relationship between 
quercetin intake to its concentrations in plasma and excretions in urine. 
Chemical analysis of food composites is a suitable method to assess the intake of 
a large number of fatty acids and sterols for subsamples of populations. We found large 
differences in the amount of these nutrients in the diets of middle-aged men living in 16 
cohorts in seven countries. Three-day records are not suitable to measure individual energy 
intake, but they can be used to classify subjects by their energy intakes. 
In conclusion, the most feasible method to assess flavonol intake in epidemiological 
studies appears to be a food frequency questionnaire specially devised to assess flavonol 
intake and validated in a sub-population by biomarkers of flavonol intake. In addition, 
chemical analysis of food composites is a good tool to assess specific fatty acids and sterols 
in the diet of a population. Finally, when using 3-day food records, even from a motivated, 
lean, well-educated population, underestimation of intakes has to be taken into account. 
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Introduction 
Diet plays an important role in the cause and prevention of various diseases 13. Examples 
are the intake of fatty acids in relation to coronary heart disease 4,s, and the intake of 
vegetables and fruit in relation to the occurrence of cancer 6. However, the outcomes of 
epidemiological studies sometimes conflict. As dietary assessment plays a crucial role in 
these studies, one of the major problems may be the imprecision of methods to assess 
dietary intake 7. Imprecise methods show large variances in intake within subjects relative 
to actual variances in intake between subjects. Imprecise methods could cause subjects to 
be classified wrongly by their nutrient intakes. As a result, correlation coefficients or 
relative risks in relation to disease could be attenuated, and relationships that are actually 
present could not be demonstrated. Methods to assess dietary intake differ in concept and 
technical application. Thus, it is important that the measurement errors of each method are 
understood in order to choose the best methods for different purposes and target groups 7'8. 
Methods of dietary assessment 
Dietary assessment methods can roughly be divided into methods assessing current diet, 
consisting of records and 24 h recalls, and methods assessing habitual diet, consisting of 
dietary histories and food frequency questionnaires. The intake data derived by these 
methods, combined with analytical data from food composition tables or from chemical 
analysis, result in individual nutrient intakes. In addition to these methods, some biological 
indicators of dietary exposure have been developed 9. 
For all methods it is important that the measurement error or variability of the 
method is not too large compared to the actual variability in intake between subjects. All 
methods suffer from measurement error, both systematic and random error, but the scopes 
of error differ between the various methods. Sources of error include underreporting of 
intake 10, incorrectly estimated portion sizes n , and missing or inaccurate nutrient data in 
food composition tables. 
In selecting a method it is important to know what type of information is required: is this 
information about individual or group intake, about foods or food groups, about all nutrients 
or only specific ones? Based on the literature, Beaton et al. 12 suggested distinguishing four 
approaches to analyses which each require a different type of information. These approaches 
are: 
1) estimation of mean intakes of a group or comparison of mean intakes across 
categories of individuals (for example by ethnicity), 
2) distributional analyses, for example to assess the proportion of individuals with 
inadequate or excessive intakes, 
3) correlation and regression analyses to assess relations between intake levels and 
outcome measurements, 
4) categorical analyses to categorize individuals by intervals of intake and by the 
occurrence of disease, as is common in epidemiological studies. 
As Beaton indicated 12, systematic error is acceptable in all but the second approach as long 
as the only question is "Is there a relationship?" and not "What is the relationship?". 
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This thesis evaluates the measurement errors of several methods to assess the intake 
of flavonoids, fatty acids, sterols, and energy. These methods are food records, a food 
frequency questionnaire, biological indicators of intake and chemical analysis of food 
composites. 
Assessment of flavonoid intake 
Flavonoids are non-nutrients in plant foods. More than 4000 flavonoids have been 
determined until now n . Some flavonoids appear to have antioxidative properties 14, which 
could explain their beneficial effect on the occurrence of coronary heart disease. Flavonoids 
are also reported to have anticarcinogenic properties. Further, effects on the occurrence of 
cancer or cardiovascular disease of some flavonoid-rich foods such as onions 15, tea 16, and 
red wine 17 have been reported. However, it is uncertain whether flavonoids were 
responsible for these effects 16. 
Flavonoids include flavonols, flavones, catechins, and anthocyanidins 13. 
Flavonols are a major compound in the diet and they appear to be strong antioxidants in 
vitro 18. Their major representatives in the diet are quercetin and kaempferol. The amount 
of another flavonol, isorhamnetin, in the diet is rather low, but it is formed in the body 
from quercetin. Flavonols in the diet are mainly derived from tea, onions, apples and red 
wine ". Some other types of vegetables or fruit, such as leek and berries, also contain high 
amounts of flavonols. 
The intake of flavonols is in the range of most vitamins, but large differences 
between countries exist (Table 1.1). The intake of flavonols and flavones in the Netherlands 
is comparable to that in the United States 20 and in the United Kingdom 21. However, the 
intake of flavonols and flavones in Finland is much lower22. Flavonol intake measured in 
the Seven Countries Study confirmed that differences in intake may be large. In the 
Netherlands 19, quercetin contributes about 70% and kaempferol 20% to the intake of 
flavonols and flavones. 
The relation between the intake of flavonols and the occurrence of disease is 
sometimes conflicting. Some studies show an inverse relationship between intake and the 
occurrence of coronary heart disease 22"25, whereas others do not 20,21. One of the major 
explanations could be that the methods used to assess flavonol intake were not suitable 26. 
In studies that showed a relationship, flavonoid intake was assessed by a dietary history 
method or by sampling of food composites. In studies that showed no effects, flavonoid 
intake was assessed by a food frequency questionnaire. The use of standard portions, 
instead of estimated or weighed portions, in the food frequency questionnaires to estimate 
the amount of flavonol-rich foods could have been inaccurate. Also, foods important for 
flavonol intake might have been lacking in the questionnaires. However, a food frequency 
questionnaire is a more feasible method to assess flavonol intake than is a dietary history 
method: the number of foods in such a questionnaire could be small, as few foods 
contribute to flavonol intake. 
It may however be questioned, whether recall and record methods are in any case 
suitable to assess flavonol intake. Flavonol intake assessed by these methods may cause 
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Table 1.1 Summary of dietary assessment methods and flavonol and flavone intake in 
epidemiological prospective studies 
Population 
Zutphen";1993 
(the Netherlands) 
Finland22;1996 
Health Professionals20; 
1996 (USA) 
Caerphilly21 ;1997 
(UK) 
Zutphen24;1996 
(The Netherlands) 
Seven Countries 
Study25;1995 
number 
of 
subjects 
n 
805 
5133 
34789 
1900 
552 
12763 
gender 
m/f 
m 
m/f 
m 
m 
m 
m 
age 
y 
65-84 
30-69 
40-75 
49-59 
50-69 
40-59 
dietary 
method' 
history 
history 
frequency 
frequency 
history 
total 
diet 
flavonol and 
flavone intake 
mg/d 
25.9 ± 14.5 
(mean ± SD) 
0 -41.4 
(range) 
3.4 
(median) 
20.1 
(mean) 
7.1 - 40.0 
(medians 1th -
5th quintile) 
26.3 ± 12.5 
(mean ± SD) 
23.5 ± 7.6 
(mean ± SD) 
2.6 - 68.2 
(range) 
' history = dietary history method; frequency = food frequency questionnaire; total diet = chemical 
analyses of food composites based on food records. 
specific problems. One problem is that flavonols are concentrated in a few foods. Therefore 
wrongly estimated portion sizes of these foods could easily lead to a large discrepancy 
between estimated and actual flavonol intake. Another problem is that the bioavailability 
of flavonols differs between dietary sources. For instance, the bioavailability of quercetin 
from apples is one third of that from onions 27. Finally, although many foods have already 
been analyzed for flavonol content, the flavonol composition of many foods, especially 
ready-to-eat foods, is unknown. These foods may contribute substantially to flavonol intake 
because they often contain onions. Also, there may be large variations in the flavonol 
content of the same foods 28. 
A biochemical indicator for flavonol intake could possibly overcome some of the 
above problems. The principle of this method is that the nutrient of interest or a metabolite 
is measured in a body fluid or tissue, such as blood or urine samples, but also toenails, hair 
and depot fat. A biochemical indicator may be used to assess intake in epidemiological and 
nutritional studies and to validate other methods of dietary assessment 9'2930. A biochemical 
indicator should be sensitive to intake within the range of habitual consumption, reflect 
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long-term intake, and preferably is related linearly to intake 9,3°. A major disadvantage of 
biological indicators is that they do not characterize the diet. Also, the variability of the 
level of the marker within subjects, superimposed on laboratory errors, may seriously 
reduce markers' usefulness. Flavonols have been measured in the plasma and urine of 
subjects after consumption of single foods 27,31 by a method developed by Hollman 32. Thus, 
concentrations of flavonols in plasma and excretion in urine might be used as biomarkers 
of flavonol intake. 
Assessment of fatty acids and sterols 
The intake of fatty acids and sterols is related to the risk of coronary heart disease 33"35 and 
to certain types of cancer 2. Saturated fatty acids, trans fatty acids and cholesterol in the diet 
affect blood lipids, which increases the risk of coronary heart disease. Yet, unsaturated fatty 
acids have effects related to a lower risk of coronary heart disease 2. However, not all types 
of fatty acids within a cluster of saturated or unsaturated fatty acids have the same 
effects 34-36-38. For instance, the saturated fatty acids myristic and palmitic acid clearly 
increase blood lipids whereas stearic acid, which is also a saturated fatty acid, has no or 
little effect 37. Also, trans-unsaturated fatty acids show adverse effects 39"43, whereas effects 
of cis-unsaturated fatty acids are thought to be beneficial. In addition, a high intake of n-3 
fatty acids, a subgroup of the polyunsaturated fatty acids, may reduce coronary mortality, 
whereas n-6-fatty acids 44,45, another subgroup, show no effect. Finally, the association of 
intake with coronary heart disease may differ between the plant sterols 46. Thus, to achieve 
more information about the effects of single fatty acids and sterols in relation to disease, 
they have to be determined separately in the diet. Otherwise, fatty acids and sterols with 
opposite effects are investigated in one score, and existing relationships will not become 
clear. 
The major sources of fat and sterols in the diet are edible fats and oils, meat, dairy 
products, and commercial and fast food products. There is a large difference between these 
foods in the type of fat present. For example, the composition of fats may differ 
considerably between processed foods 47 because various fats and oils may be used in their 
manufacture. 
Fatty acids and sterols in the diet have been measured by various dietary assessment 
methods. Food disappearance data have often been used but they are only indirectly related 
to actual intake. Also, record and recall methods are often recommended to assess fat 
intake, but they are not suitable to measure single fatty acids and sterols. The major reason 
is that these methods need food composition tables, and most tables have no data on 
specific fatty acids and sterols or the data are insufficient or inaccurate. Methods that do 
not need food composition tables are biological indicators and chemical analysis of food 
composites. 
Biological indicators of fatty acids have already been developed and validated. 
Certain fatty acids in blood, urine or fat tissue may be used as indicators of intake 48"52. 
However, they are not available for all important fatty acids or for sterols. Also, chemical 
analysis of food composites has already been successfully applied to assess the intake of 
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fatty acids 53. This method chemically analyses fatty acids and sterols in a food composite. 
This composite consists of all food items which are collected, based on the known average 
dietary intake of the population at large or at risk 54. An advantage of this method is that 
information is derived from real foods. Disadvantages are that the accuracy of intake data 
relies on that of reported data and that no information is available about the ranges in 
individual intake. Thus, chemical analysis of food composites successfully determines the 
presence of more single fatty acids and sterols than do methods needing food tables 53, but 
only for a group. 
Assessment of energy intake 
Energy intake is often assessed by record or recall methods. Using food records, which are 
often applied in studies, subjects record the type and portion size of all foods they eat. They 
estimate portion sizes or weigh the foods on a scale. Food records for several days have 
often been regarded as the most accurate method to determine dietary intake. However, 
studies performed during the last ten years have shown that this method also suffers 
severely from underreporting 10,55. Obese subjects 56'57, women, and older persons in 
particular appear to underestimate their intake 58. In addition, subjects need a certain grade 
of literacy to provide adequate self-reports by records. In line with this, non-obese adults 
in western countries have provided the best reports 10. 
Aim of the thesis 
There is increasing doubt about the validity of recall and record methods including food 
records. These methods are not precise enough to assess the intake of nutrients and non-
nutrients lacking data in food composition tables, or whose bioavailability differs between 
the most important sources in the diet. Also, these methods are not precise enough to assess 
nutrients that have a large day-to-day variation. Methods that are possibly better qualified 
to assess the intake of these nutrients are biochemical indicators of intake and chemical 
analysis of food composites. The aim of this thesis was to evaluate physically and 
chemically based methods to assess the intake of certain nutrients lacking accurate data 
in food composition tables or nutrients whose bioavailability differs between foods. To 
that end, we selected and evaluated methods to assess the intake of flavonoids, fatty acids, 
sterols, and energy. This thesis focused on the following sub-questions: 
- How large are the within- and between-subject variations of flavonol intake as reported 
in food records or in a food frequency questionnaire by free-living subjects (Chapter 2)? 
- Is it necessary to account for differences in the bioavailability of flavonols from tea, red 
wine and onions (Chapter 3 and 4)? 
- Are flavonols in plasma and urine useful biomarkers of flavonol intake (Chapter 4 and 
5)? 
- Can chemical analysis of food composites identify differences in the intake of fatty acids 
and sterols between populations (Chapter 6)? 
- Do food records provide valid estimations of energy intake in young, non-obese, and 
well-educated adults (Chapter 7). 
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Abstract 
Quercetin and related flavonoids are anticarcinogenic in rats, but little is known about 
human intakes. The intake of five major flavonols and flavones was calculated using 1-day 
dietary records of 17 volunteers from 14 countries, and using both 3-day records and a food 
frequency questionnaire of eight Dutch adults. Total consumption (± SD) was 27.6 ± 19.5 
mg/d in the international subjects, 34.1 ± 31.2 mg/d in the Dutch adults according to 3-day 
records, and 41.9 ± 23.7 mg/d according to questionnaires. Quercetin contributed 68-73%, 
and kaempferol 22-29%, the major sources being tea and onions. A brief food frequency 
questionnaire may be a suitable method for ranking individuals by flavonol intake. 
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Introduction 
Flavonoids, a group of polyphenolic compounds with antioxidant properties, are widely 
distributed in foods of plant origin such as vegetables, fruit, tea and wine ''2. It has been 
suggested that the consumption of flavonols and flavones, a subgroup of the flavonoids, 
would protect from cancer 3. Furthermore, beneficial associations with the occurrence of 
coronary heart disease have been reported 4. 
Within the subgroup of flavonols and flavones the flavonol quercetin is the major 
compound in foods, with smaller contributions from kaempferol, myricetin, and the flavones 
apigenin, and luteolin 5. The main sources of flavonols and flavones are tea and onions 5. 
The most important flavonol in onions is quercetin 1, whereas tea contains considerable 
amounts of both quercetin and kaempferol 2. 
In order to study the relation of flavonoids in the diet with chronic diseases a 
method for ranking of individuals by flavonoid consumption is needed. For evaluation of 
dietary assessment methods information is needed about the main dietary sources and the 
within- and between-subject variations. For these purposes, we calculated the intake of the 
five flavonols and flavones from three existing datasets, obtained with 1-day records, 3-day 
records, and a food frequency questionnaire. 
Methods 
Subjects and design 
Thirteen non-resident aliens and 4 Dutch subjects consuming non-traditional diets enroled 
in the "international" part of the study. These participants, 6 men and 11 women from 14 
countries and 4 continents, ate a wide variety of diets (Table 2.1). Their mean age was 29 
± 7 (±SD), and their body mass index 21 ± 3 kg/m2. Four female and 4 male Dutch 
subjects, aged 25 ± 9 y (mean ± SD), with a body mass index of 23 ± 5 kg/m2 consumed 
a normal Dutch diet (Table 2.2). All subjects were healthy and gave their written informed 
consent for participation in the study. The protocol was approved by the Medical Ethics 
Committee of the Department of Human Nutrition. 
Dietary assessment 
The 17 "international" subjects weighed and recorded all foods and beverages, including 
herbs and spices, in a diary for 1 day. The 8 Dutch subjects recorded their foods and 
beverages in household measures for 2 weekdays and 1 weekend day, and filled out a 74-
item food frequency questionnaire which specifically asked about the habitual consumption 
of flavonoid-rich foods such as vegetables, fruit, beverages, ready-to-eat meals containing 
onions, herbs, and spices. Trained dieticians checked the food records and the 
questionnaires. 
The intake of 5 flavonols and flavones (quercetin, kaempferol, myricetin, luteolin, 
and apigenin) was calculated using published values for contents in vegetables, fruit and 
beverages u , supplemented with values for other Dutch foods including herbs and spices, 
and some American and Italian foods, also determined at the RIKILT-DLO laboratory 
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(Hollman P.C.H, unpublished data), using an identical method 6. We calculated energy and 
dietary fibre intakes using the computerized version of the Netherlands Nutrient Data Bank 
NEVO 7. We assessed the between and within subject variations by analysis of variance 
using SAS procedure ANOVA 8. 
Results 
In the 17 international subjects, intake of energy was 9.0 ± 3.1 MJ (mean ± SD), and mean 
intake of dietary fibre was 1.7 g/MJ of energy. The lowest consumption of the 5 flavonols 
and flavones was 3.6 mg/d for the subject with a South-American diet, whose single source 
was a small amount of onions (Table 2.1). The highest value was 77 mg/d for the subject 
with a Scandinavian diet, who drank almost 2 litres of tea on the day records were kept. 
The between-subject coefficient of variation was 70%. The mean contribution of quercetin 
to the total flavonol plus flavone consumption was on average 73%, of kaempferol 22%, 
Table 2.1. Flavonol and flavone intake in subjects eating a variety of diets according to 
a 1-d weighed food record, including herbs and spices. 
Subject 
1 
2 
3 
4 
4 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
Mean ± sd 
Country of origin 
USA 
China 
Czechoslovakia 
Ethiopia 
Finland 
India 
Indonesia 
Italy 
Lithuania 
Malaysia 
Mexico 
The Netherlands 
The Netherlands 
The Netherlands 
The Netherlands 
Surinam 
Turkey 
Type of diet 
Macrobiotic 
Chinese 
East-european 
African 
Scandinavian 
Asian 
Asian 
Mediterranean 
East-european 
Asian 
South American 
Lacto-ovo vegetarian 
Vegetarian 
"Prehistoric" * 
Western 
Surinam 
Middle-eastern 
Intake of flavonols 
plus flavones 
mglday 
15.7 
5.1 
24.2 
52.9 
77.0 
15.6 
28.3 
15.3 
13.2 
12.7 
3.6 
50.3 
26.3 
26.8 
47.7 
35.4 
19.8 
27.6 ± 19.5 
' uncooked and unprocessed products, vegetables and fruit were typical of this diet 
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and of myricetin 4%. The intakes of luteolin and apigenin were almost at zero. Tea was the 
major source contributing 37% of flavonols and flavones, followed by onions 26%, 
vegetables 14%, fruits 22%, and red wine 1%. 
In the 8 Dutch adults the daily energy intake was 10.6 ±1.5 MJ, and the mean 
dietary fibre intake 2.2 g/MJ of energy according to the 3-d records. Flavonol plus flavone 
intake calculated from the food records ranged from 1 to 81 mg/d, and from the food 
frequency questionnaires from 9 to 75 mg/d (Table 2.2). The mean contribution of quercetin 
to the total flavone and flavonol consumption according to 3-d records and food frequency 
questionnaires was 68% for both, of kaempferol 28% and 29%, and of myricetin 4% and 
2%, respectively. The contributions of luteolin and apigenin were again negligible. 
Table 22. Habitual flavonol and flavone consumption of 4 Dutch men and 4 Dutch women 
according to 3-d records and a food frequency questionnaire for assessment offlavonoid 
intake. 
Subject 
1 
2 
3 
4 
5 
6 
7 
8 
Mean ± sd 
Age 
21 
24 
22 
47 
21 
25 
22 
20 
Sexe 
male 
male 
female 
male 
female 
female 
female 
male 
Flavonoids 
3-d records 
mglday 
11 
1 
24 
2 
28 
81 
71 
55 
34.1 ± 31.2 
Flavonoid 
questionnaire 
mglday 
9 
37 
27 
33 
25 
72 
75 
57 
41.9 ± 23.7 
The within- and between-subject coefficients of variation calculated from the 3-d records 
were 63% and 84%, respectively. The ratio of the within-subject and between-subject 
components of variance was 0.57. The between-subject coefficient of variation calculated 
from the food frequency questionnaires was 56.5%. Tea contributed 47% to the total 
amount of the five flavonols and flavones according to 3-d records, and 28% according to 
the food frequency questionnaires, onions 26% and 34%, vegetables 20% and 27%, fruits 
6% and 11%, and red wine 1% and 0%, respectively. The correlation coefficient between 
the 3-d records and the food frequency questionnaires in the full Dutch group was 0.85 
(n=8). 
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Discussion 
We found marked differences of up to 80 mg/d in flavonol and flavone intake between free-
living subjects. Tea and onions were the most important sources forflavonoid consumption 
in both groups. The between-subject coefficient of variation was higher in the 
"international" than in the Dutch group. The variation within subjects in the Dutch subjects 
according to the 3-d records was large, and comparable with, for example, vitamin C in US 
women 9. However, in contrast with many nutrients the ratio of within- and between subject 
variance was lower than 1 9. The relatively large between-subject variation gives a fine 
opportunity to study the relation between flavonoids and health. 
The results of 1 or 3-day records were possibly not sufficient to represent the long-
term average daily individual intake. The within-subject coefficient of variation of 63% 
suggests that the number of days needed to estimate the individual intake within 20% of 
the actual intake 95% of the time is 38 days 10. The results of the food frequency 
questionnaire probably provided the best data as this method inquired after food intake over 
30 days. The high correlation coefficient of this method with the 3-d records suggests that 
these methods are similar for ranking of individuals. 
We did not have flavonol values for all plant foods consumed by the subjects. 
However, we have lacked only the data of a few foods, for example, citrus fruits, which we 
do not expect to contribute significant amounts of flavonols and flavones 2. Therefore we 
probably made only a small underestimation of actual flavonoid intake. The contribution 
of herbs and spices to flavonol and flavone intake was at most 3 mg/d. 
The flavonol and flavone intake of all subjects was within the distribution of 
flavonoid intake in the Netherlands 5, although some subjects were at the highest intake 
range. Hertog 4,s also found tea and onions to be the major sources of flavonol and flavone 
consumption. However, the contribution of tea that he found in elderly men (61%), and in 
Dutch adults (48%) was higher than in our study. 
We conclude that there was a large variation in flavonol and flavone consumption 
in this study, but the within-subject variation was less than the between-subject variation. 
For ranking of subjects for flavonoid intake, a short food frequency questionnaire appears 
to be suitable. However, it needs to be tested in a larger study. 
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Abstract 
Coronary mortality in France is low even though the intake of saturated fat is high. This 
so-called French paradox has been ascribed to a high consumption of red wine. Red wine 
is thought to be an important source of polyphenolic antioxidants, especially flavonols, and 
consumption of wine may therefore prevent LDL oxidation and atherosclerosis. We 
compared the bioavailability of flavonols from wine with that from onions and from tea. 
Twelve healthy men consumed 6 glasses of red wine, 50 g of fried onions or 3 cups of 
strong black tea, in random order. Concentrations of flavonols in plasma and their 
excretions in urine on red wine were lower than or similar to those on onions or tea. We 
conclude that red wine is a poor source of flavonols. Thus, intake of polyphenolic 
antioxidants from red wine cannot explain the French paradox, and red wine may not be 
superior to other alcoholic beverages in preventing heart disease. 
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Introduction 
Mortality from coronary heart disease is low in France, even though saturated fat intake is 
high '. This so-called French paradox has been ascribed to a high consumption of red 
wine 2, the idea being that polyphenols from red wine prevent oxidation of low-density 
lipoproteins. Red wine contains polyphenols such as flavonols, catechins, resveratrol 3, 
anthocyanins, and proanthocyanidins. Polyphenols, and especially the flavonol quercetin are 
potent inhibitors of LDL oxidation in-vitro 4. However, it is unknown to what extent 
quercetin and other flavonols are absorbed from wine in man. We now compared the 
bioavailability of flavonols from red wine with that from two other important sources, tea 
and onions. 
Methods 
The Medical Ethical Committee of the Division of Human Nutrition and Epidemiology 
approved the study. Twelve healthy male subjects (mean age 25 years, mean body mass 
index 22 kg/m2) were thoroughly informed about the study, and they filled out and signed 
an informed consent form. The subjects consumed six 125-ml glasses of a red wine selected 
for its high flavonol content (Medoc Chateau Latour St. Bonnet 1993), or 50 grams of fried 
onions, or three 125-ml cups of extra-strong black tea daily during four days in random 
order with a wash-out of three days between treatments. Subjects followed a diet low in 
flavonols. The wine provided 14.2 ± 0.3 mg (± SD), the onions 15.9 ± 0.5 mg, and the tea 
13.7 ± 1.6 mg of quercetin per day. We told the subjects to consume one-third of the wine 
or tea at lunch, one-third at dinner, and one-third between 10.00 and 12.00 pm; 
consumption of onions was divided between lunch and dinner. On day 4 blood was sampled 
after lunch, and urine was collected for 24 hours. 
Table 3.1 Effects of daily consumption of 750 ml red wine rich in the flavonoid quercetin, 
of 50 g of fried onions, and of 3 cups of black tea on concentrations of flavonols in plasma 
in 12 healthy men 
Treatment 
Red wine 
Fried onions 
Black tea 
Quercetin 
8 ± 3a 
1 6 ± 5 b 
8 ± 4 a 
Plasmaconcentration* 
Kaempferol 
Hg/L 
1 ± la 
1 ± 0a 
4 ± 2b 
Isorhamnetin 
3 ± 2a 
2 ± lb 
1 ± lb 
" x ± SD, average of two blood samples per subject 
"" Values in the same column with different superscript are significantly different from each other 
(p<0.05) 
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Results 
Quercetin levels in plasma and urine 5 after red wine were significantly higher than 
baseline, but lower than after onions, and almost similar to those after strong tea (Tables 
3.1 and 3.2). Kaempferol after wine was the same as after onions, but lower than after tea; 
isorhamnetin was highest after wine. 
Table 3.2 Effects of daily consumption of 750 ml red wine rich in the flavonoid quercetin, 
of 50 g of fried onions, and of 3 cups of black tea on amounts excreted in 24-h urine in 12 
healthy men 
Treatment Urinary excretion 
Quercetin Kaempferol Isorhamnetin 
Red wine 
Fried onions 
Black tea 
112 ± 33a 
153 ± 66a 
76 ± 45b 
Hg/24hr 
72 ± 25a 
95 ± 139a 
202 ± 116" 
106 ± 58" 
55 ± 26b 
29 ± 27a 
,,b
 Values in the same column with different superscript are significantly different from each other 
(p<0.05) 
Discussion 
Thus some of the flavonols from red wine were absorbed. However, plasma concentrations 
of the sum of flavonols after 750 ml (6 glasses) of red wine were the same as after 3 cups 
of tea, and lower than after 50 g of onions. The wine and tea used here had about two times 
the quercetin content found normally. This means that consumption of one glass (125 ml) 
of red wine with an average content of quercetin 6 would produce plasma quercetin levels 
similar to those after consumption of Vi cup (125 ml) of average tea or 5 grams of onions. 
The French drink on average 3 glasses of wine per day \ and the flavonol content in French 
wines is about half that in our study 6. Therefore, daily intake of flavonols from wine in 
France - including the flavonol myricetin - does not exceed 10 mg per day. In the 
Netherlands the average daily intake of flavonols from tea is 11 mg and from onions 7 mg 
per day 6; in the UK the intake from tea is 21 mg per day 7. Therefore, the intake of 
bioavailable flavonols from wine in France is quite modest, and cannot explain the 
difference in coronary heart disease between France and other countries. Probably, other 
phenolics in wine also cannot explain the French paradox; the level of catechins in red 
wine 3 is lower than in tea 8, and the amount of resveratrol is probably too low to show 
anti-oxidant activity in-vivo 4. It is uncertain whether anthocyanins and proanthocyanidins 
could play a role. Also no specific effect of red wine was apparent in a meta-analysis of 
the cardioprotective effect of alcohol 9. Intake of flavonols and probably also other 
polyphenols substances from red wine cannot explain the French paradox. 
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Abstract 
Flavonols are antioxidants that may reduce the risk of coronary heart disease. Two major 
flavonols in the diet are quercetin and kaempferol, and their main sources are tea and 
onions. We investigated whether plasma concentrations and urinary excretion of quercetin 
and kaempferol in humans could be used as biomarkers of intake. We provided 15 subjects 
with strong black tea (1600 ml/d) or fried onions (129 g/d) for 3 days each in random 
order, separated by a 4 day wash-out. The tea provided 49 mg quercetin and 27 mg 
kaempferol daily, and the onions 13 mg of quercetin, and no kaempferol. Flavonols from 
both foods were clearly absorbed. However, the excretion of unmodified quercetin was 
0.5% of intake after tea, and 1.1% after onions. Thus, the absorption of quercetin from tea 
is half of that from onions. The onion supplementation period was repeated 7 - 14 d later, 
so as to estimate coefficients of variation within subjects when the same treatment is given 
twice. Coefficients of variation were 30% for quercetin in plasma and 42% in urine. The 
magnitude of these variations relative to actual variations of about 60% between free-living 
subjects indicate that levels of quercetin in plasma and urine are applicable as biomarkers 
of its intake. We conclude that flavonols in plasma and urine reflect flavonol intake, and 
that they could be applied as biomarkers to distinguish between high and low flavonol 
consumption in epidemiological studies. 
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Introduction 
Flavonoids, a group of polyphenols compounds, are widely present in vegetables, fruit, tea, 
and wine '2. A main subgroup of the flavonoids are the flavonols, of which quercetin and 
kaempferol are the major representatives 3'4. Onions are an important source of quercetin 
in the diet, and tea of both quercetin and kaempferol 1,z. 
Beneficial effects of dietary flavonols in the diet on the risk of coronary heart 
disease have been suggested by epidemiological studies 5, but whether these components 
can prevent heart disease is still controversial 6. Protective effects of flavonols against 
cancer have also been proposed 7, but epidemiological data hitherto fail to support this 8'9. 
Further studies investigating the relation of flavonols with disease are needed. Such 
studies require an accurate method to assess intake of flavonols in free-living subjects. 
However, it is difficult to assess flavonol intake by common dietary record or recall 
methods. Such methods rely on self-report and their accuracy is therefore uncertain 10,n. It 
is also difficult to assess true daily flavonol intake because flavonols are concentrated in 
a few foods 1213. Therefore, small errors in the assessment of the consumption of these few 
flavonol-rich foods result in large errors in estimated flavonol intake. Also, when record or 
recall methods are used, the intake of flavonols has to be calculated from the flavonol 
content of foods. The flavonol content of many foods is not known, and they are not 
commonly included in nutrient databases. Moreover, these methods do not take into account 
the bioavailability of flavonols which varies widely between foods M. For example, the 
percentage of quercetin absorbed from apples was only one-third of that from onions 15. For 
many foods, tea for one, absorption has not even been reported yet. The use of biomarkers 
of intake can bypass most of these problems. 
Like other dietary assessment methods, biomarkers suffer from measurement error. 
This error consists of random and systematic errors 16. Random error includes within-subject 
fluctuations, metabolic between-subject differences, and imprecision in laboratory analyses. 
Random error can be determined by studying the reproducibility of the level of the marker 
at constant levels of intake. To determine this reproducibility the same treatment has to be 
given twice in the same individual. Systematic errors cannot be determined easily, but this 
error is possibly much smaller for biological measurements than for record or recall 
methods. 
The objective of our study was to determine whether levels of flavonols in plasma 
and urine may be used as biomarkers of their intake. A second objective was to compare 
the bioavailability of flavonols from tea and onions. Therefore we measured concentrations 
of quercetin and kaempferol in plasma and excretions of these flavonols in urine after 
feeding volunteers tea or onions, and we repeated the treatment with onions to determine 
reproducibility. 
Subjects and methods 
Subjects 
We obtained approval from the Ethics Committee of the Division of Human Nutrition and 
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Epidemiology. We recruited eight men and seven women via posters and local newspapers, 
and informed them about the aim of the study and possible discomforts that it could entail. 
The subjects gave their written informed consent. They were medically evaluated and 
considered healthy by a physician. The mean age of the subjects was 27.6 y (range 
19 - 56 y), and their mean body mass index was 23.5 kg/m2 (range 19.7 - 30.9 kg/m2). 
Design 
The experiment lasted 3 weeks. The 3 treatments were provided in random order, and each 
treatment was given for 3 days on days 5 to 7 of each week (Figure 1.1). Days 1 to 4 
served as a wash-out period. The tea treatment consisted of 1600 ml concentrated black tea 
and the onion treatment of 129 grams of fried onions, both divided over the day. The 
treatment period with onions was performed twice to assess reproducibility within subjects. 
Day 1 
Lithium 250 (xmol/day 1 
Diet low in flavonols 
1600 ml tea or 129 grams of onions 
24-hour recall 
10 ml blood sample 
24-hour urine 
2 3 4 
L 
5 6 7 
Figure 4.1 Design of one study week. The experiment consisted of 3 study weeks; each 
subject took tea in 1 week and onions in the two other weeks, in random order 
On days 4 to 7 of each treatment week (Figure 4.1) the subjects followed a low-quercetin 
diet. For this purpose they were given a list of vegetables and fruits containing > 15 mg 
quercetin/kg and of beverages containing > 4 mg quercetin/L ',2 and were instructed not to 
consume any of these. On day 7 of each week blood was sampled and urine was collected 
for 24 hours. On the morning of day 4 of the second week of treatment, blood was sampled 
to determine baseline values for plasma quercetin. At this time point the subjects had 
followed the quercetin-low diet for 1 day, and they had not yet started consuming the 
second series of supplements. For the baseline value of kaempferol in plasma the 
concentration after consumption of onions was used as a surrogate, because onions do not 
contain kaempferol '. Eight months after the experiment we repeated one treatment week 
in 8 of the 15 subjects without providing supplements so as to collect baseline values for 
urine. During all treatment weeks subjects recorded all deviations from the guidelines in a 
diary. Medications were not allowed except for oral contraceptives and paracetamol. 
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Supplements and diets 
Tea was made 3 times per day. One litre of boiling water was poured on 4 tea bags 
(Pickwick, Douwe Egberts) containing 16 grams of black tea leaves, which is twice the 
quantity for normal use. The tea was allowed to brew for five minutes. The tea supplements 
provided on average 49 ± 4 mg (± SD, 9 samples) quercetin and 27 ± 2 mg kaempferol per 
day, as determined by HPLC " in duplicate. Prior to the study, eighteen 1 kg portions of 
yellow onions from a single batch were fried with 68 grams of margarine per kg for nine 
minutes. All fried onions were mixed, weighed out in portions of 43 grams in plastic pots, 
and frozen at - 20 °C until supplementation. Just before consumption, the onion 
supplements were heated in a microwave oven for 1 minute and served with a slice of 
bread. The onion supplements contained 13 ± 1 mg (mean ± SD; n=4) quercetin 17; the 
content did not diminish during 3 weeks storage in a freezer or after heating in a microwave 
oven (399 mg/kg after frying versus 396 mg/kg after subsequent freezing and reheating). 
Between 8:00 and 9:00 am, 12:00 and 1:00 pm, and again between 4:00 and 5:00 pm, 
subjects consumed the onion supplement under our supervision or received the tea 
supplement in a thermos jug. 
We checked compliance to the low quercetin diet by 24 hour recalls. Quercetin and 
kaempferol intakes were calculated using our published values for contents in vegetables, 
fruit and beverages 12. 
Collection of blood and urine samples 
Venous blood samples were taken between noon and 1:00 pm as described 18. Urine 
samples were collected by each subject in 500 ml and 1000 ml bottles which contained 
thymol dissolved in isopropanol as a preservative. The first urine voiding after rising in the 
morning was discarded and all subsequent urines until the next morning, including the first 
urine after rising, were collected. The urine bottles were immediately put into polystyrene 
boxes containing dry ice. Within 1 to 5 days the urines were thawed at 40° C, pooled per 
subject per day, and aliquots were stored at - 40 °C until analyses. Completeness of urine 
was checked by assessment of recovery in urine of 2.0 mg of lithium (235 pimol) as lithium 
chloride dissolved in 10 ml water taken by the subjects every morning. On days 5, 6, and 
7 they took this under our supervision. The dose of 2 mg/d of lithium is 1% of that 
considered safe for chronic use in patients with bipolar disorders 19. The recovery in urine 
of orally ingested lithium is about 95% 20'21. 
Analytical methods 
Quercetin, kaempferol and their conjugates in plasma or urine were simultaneously 
extracted and hydrolysed to the aglycone using 2 M HC1 in aqueous methanol 15, and 
determined by HPLC with fluorescence detection 22. The limit of detection was 2 pig/L for 
quercetin, and 0.6 ng/L for kaempferol. 
Lithium was analysed in a separate undiluted acidified urine sample by atomic 
absorption spectrophotometry 23. 
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Statistical analysis 
Data are reported as mean ± SD. To achieve normality we converted the amounts of 
quercetin analyzed in urine to 10log values. We determined within- and between-subject 
coefficients of variation for quercetin levels in plasma and urine after the two treatments 
with onions using the SAS procedure VARCOMP. We calculated confidence intervals for 
Pearson correlation coefficients using Fisher's Z transformation. 
Results 
Variability and reproducibility 
Reproducibility on the 2 treatments with onions was similar for quercetin in plasma and in 
urine. Between the first and the second treatment with the same intake from onions the 
coefficients of variation within subjects were 20% for plasma concentrations, and 22% for 
urinary excretion. The coefficient of variation between subjects given identical treatments 
was lower for plasma than for urine; it was 23% for concentrations in plasma and 36% for 
excretions in urine. The correlation between the concentrations of quercetin in plasma and 
the amount excreted in urine, taken as the averages for each individual after tea and onions, 
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Figure 4.2 Correlation between the excretions of quercetin in 24-hour urine after 
consumption of tea and after that of onions in 15 subjects. The subjects consumed 1600 ml 
tea providing 49 mg, and 129 grams of onions providing 13 mg of quercetin per day during 
three days for each treatment. Quercetin excretions after onions were the average of two 
treatments. 
Biomarkers for flavonol intake 41 
was 0.46. It was higher than that for kaempferol after tea, which was 0.19. However, when 
we dropped one outlying value the correlation for kaempferol increased to 0.43. The 
individual excretions of quercetin after consumption of tea and after onions correlated well. 
The Pearson correlation coefficient was 0.77 (Figure 4.2). 
Table 4.1 Effect of the consumption of tea or onions on levels of quercetin in plasma and 
24-hour urine in 15 subjects. Each subject received 1600 ml strong tea or 129 grams of 
fried onions for 3 days. 
Type 
Baseline 
Tea 
Onions 
Period l3 
Period 23 
Average 
Supplement 
Amount of quercetin 
mg/day1 
0 
49 ± 4 
13 ± 1 
13 ± 1 
13 ± 1 
Quercetin 
in plasma 
Hg/L1 
7 ± 4 
29 ± 8 
22 ± 5 
22 ± 7 
22 ± 5 
Quercetin 
Absolute 
amount 
Hg/day1 
30 ± l l 2 
258 ± 150 
140 ± 66 
131 ± 72 
135 ± 66 
in urine 
Relative 
amount 
% of intake 
0.5 ± 0.3 
1.1 ± 0.5 
1.0 ± 0.6 
1.1 ± 0.5 
Values are means ± SD, ' expressed as aglycone, 2 determined in 8 of 15 subjects 
1
 the onion supplement was repeated once to assess variability 
Quercetin and kaempferol in plasma and urine 
The concentrations of quercetin in plasma after consumption of tea and after onions, and 
of kaempferol after tea were increased in all subjects. The concentration of quercetin in 
plasma was on average 4 times higher after tea and 3 times higher after onions than at 
baseline (Table 4.1). The concentration of kaempferol in plasma after tea was on average 
more than 6 times higher than the surrogate baseline concentration after onions (Table 4.2). 
The amount of quercetin excreted in urine after consumption of tea was 8 times and after 
onions 4 times higher than that after the diet low in quercetin (Table 4.1). However, if both 
were expressed as a percentage of the amount consumed (Table 4.1, Figure 4.3) the relative 
excretion of quercetin after onions was twice as high as that after tea. Differences in total 
urinary excretion of quercetin between treatment and baseline were on average 230 ± 158 
Hg/d after tea and 124 ± 85 ng/d after onions. The amount of kaempferol excreted in urine 
after tea was 25 times higher than at baseline, and 7 times higher than after onions 
(Table 4.2). If expressed as a percentage of intake, the relative excretion of kaempferol after 
tea consumption was twice that of quercetin. Differences in excretion of kaempferol 
between treatment and baseline were 586 ± 197 ng/d after tea, and 74 ± 68 Lig/d after 
onions. 
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Compliance with diets and completeness of urine collection 
The subjects consumed all their supplements, except for one subject who did not drink all 
her tea on the third day of the tea period. The average intake of quercetin plus kaempferol 
from the background diets as determined by 24 h recalls was low. It was on average 2 ± 
2 mg/d for the baseline period (n=8) and 2 ± 2 mg/d for all treatment periods combined 
(n=3xl5). 
Lithium recoveries were 87 ± 13% (± SD;n=8) in the baseline period, 93 + 11% 
(n=15) after the tea, 97 ± 9% (n=15) after the first, and 96 ± 6% (n=15) after the second 
treatment with onions. 
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Figure 43 The amount of quercetin excreted in 24-hour urine after consumption of tea and 
after that of onions as a percentage of the amount consumed per subject. Quercetin 
excretions after onions are the averages of two treatments. 
Discussion 
Biomarkers of intake 
The first objective of our study was to determine whether levels of flavonols in plasma and 
urine may be used as biomarkers of their intake. Our results suggest that plasma 
concentrations of quercetin and kaempferol and their excretions in urine can indeed be used 
as markers of their intake. A prerequisite of a biomarker is that differences in consumption 
can be discriminated 16. In our study, the consumption of quercetin and kaempferol from 
tea and onions increased their plasma concentrations and urinary excretion 3 to 25-fold. A 
low quercetin intake - as from the background diet - resulted in low levels of quercetin, and 
an average intake of quercetin - as after onions, which provided 13 mg or 80% of the 
average daily Dutch consumption of quercetin - elevated plasma and urine levels of 
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quercetin clearly in all subjects compared to baseline. However, a low intake of kaempferol, 
as after onions which do not contain kaempferol, did not result in low excretion of 
kaempferol (Table 4.2). This may be explained by consumption of kaempferol-rich 
vegetables from the background diet by some subjects. A high intake of quercetin and 
kaempferol - as after tea in our study - resulted in the highest plasma and urine levels of 
both flavonols. Thus, our study shows that levels of quercetin and kaempferol in plasma 
and urine reflected levels of intake. 
Table 42 Effect of the consumption of tea or onions on levels of kaempferol in plasma and 
24 hour urine in 15 subjects. Each subject received 1600 ml strong tea or 129 grams of 
fried onions for 3 days. 
Type 
Baseline 
Tea 
Onions 
Period l2 
Period 22 
Average 
Supplement 
Amount of kaempferol 
mglday 
0 
27 ± 2 
< 2 
< 2 
< 2 
Kaempferol 
in plasma 
fig/L 
not determined 
15 ± 5 
3 ± 4 
1 ± 1 
2 ± 2 
Kaempferol 
Absolute 
amount 
fig/day 
26 ± 71 
668 ± 360 
123 ± 157 
63 ± 27 
93 ± 75 
in urine 
Relative 
amount 
% of intake 
2.5 ± 1.3 
Values are mean ± SD. 
1
 determined in 8 of 15 subjects 
2
 the onions supplement was repeated once to assess variability 
Another requirement for a biomarker is a certain degree of precision with which 
intake can be assessed. To evaluate this, the coefficient of variation of a single estimate in 
a single subject has to be determined. The coefficient of variation for quercetin in plasma 
or urine includes random biological fluctuations within subjects, and variations between 
subjects due to differences in absorption and metabolism between subjects. The correlation 
of 0.77 between urinary excretions of quercetin after onions and those after tea showed that 
there are indeed consistent differences in flavonoid metabolism between subjects 
(Figure 4.2): subjects with a low or high excretion after onions showed a low or a high 
excretion after tea, respectively. 
For plasma, the coefficient of variation between 2 measurements on the same intake 
of quercetin from onions was 20% within subjects. The coefficient of variation between 
subjects was 23%. Thus, the total observed coefficient of variation of quercetin in plasma 
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sampled once at the same intake can be estimated as \/(202 + 232)= 30%. A similar 
calculation yields a total coefficient of variation of 42% for the measurement of quercetin 
in urine. Whether this measurement error has to be considered as large or small can only 
be evaluated in relation with the actual variation in intake found between free-living 
subjects. From various studies 5)3'2425 it can be estimated that the coefficient of variation for 
true differences in intake between subjects in the population is about 60%. This suggests 
that the random error in our proposed biomarkers is modest relative to the expected 
variations due to true variation in intake. We will illustrate the degree of precision of 
quercetin in plasma and urine as biomarkers of their intake for two hypothetical examples 
with practical applications. 
The first example addresses assessment of the compliance of a subject in an 
intervention study with a diet that provides 50 mg of quercetin per day. The interval in 
which plasma quercetin of one of the subjects is predicted to lie with a probability of 95% 
is ix ± 1.96 x a, where LX denotes the expected mean level and o the standard deviation of 
the measurement 26. After an intake of 13 mg of quercetin per day the average concentration 
of quercetin in plasma in our subjects was 22 pig/L with a coefficient of variation of 30%. 
If we assume (de Vries et al, unpublished observations) that the levels of quercetin in 
plasma and urine increase linearly with the dose then the expected level in plasma of a 
subject with an intake of 50 mg per day is 22 * 50/13 = 85 (ig/L. If the coefficient of 
variation is the same at various levels then the standard deviation will be 30% of 85 Lig/L 
or 25.5 ng/L and the 95% confidence interval will range from 85 - 1.96 * 25.5 = 35 ng/L 
to 85 + 1.96 * 25.5 = 135 ng/L. Thus, there is reason to doubt dietary compliance of the 
subject if a single plasma quercetin is less than 35 |J.g/L. Better precision can be achieved 
by taking more plasma samples: for a mean of two measurements the lower boundary point 
for compliance would be 50 \ng[L. 
Bioavailability 
The second example addresses the correlation coefficient between quercetin intake and a 
continuous variable e.g. the oxidizability of LDL. For this we estimate the attenuation factor 
of the correlation coefficient caused by measurement error. The attenuation factor is the 
ratio of the observed correlation to the "true" correlation. The factor is calculated as 
v/(l/(l+o2a/(n*o2b)), in which a2a denotes the variance of the measurement, o2b the true 
variance of intake between subjects, and n the number of measurements 26,27. From our data 
we estimate that the attenuation factor for a single measurement of quercetin in plasma or 
urine is V (l/(l+30%/lx60%) = 0.82 for plasma and v/(l/l+43%/lx60%) = 0.76 for urine. 
This implies that when the true correlation between quercetin intake and for example 
lagtime of LDL-oxidation is 0.5, the observed correlation will be 0.4. The attenuation 
factors we found for the quercetin markers are similar to those for intake measurements of 
energy and various nutrients by the cross-check dietary history method 28. 
The second objective of our study was to determine whether the bioavailability of 
flavonols from tea is similar to that of onions. Our results show that quercetin and 
kaempferol from tea are absorbed, but that the bioavailability of quercetin from tea is less 
than that from onions. Plasma concentrations of quercetin were 30% and urinary excretions 
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100% higher after tea than after onions, but the intake from tea was about fourfold higher 
than from onions. When adjusted for intake - as shown by the urinary excretion relative to 
the amount consumed (Table 4.1) - the absorption from tea was about half that of onions. 
The reason could be that the absorption of a higher dose is relatively lower, but it is more 
likely that the difference in type of quercetin conjugate present in the two foods plays a 
role. The absorption of quercetin-rutinoside, the major quercetin compound in tea, is 
probably less than that of quercetin-glucoside, the major compound in onions. 
This is in agreement with the differences in absorption we found between these two 
compounds in previous studies 14. In ileostomy patients, quercetin in 13 h urine collections 
was 0.3% of intake after onions and 0.1% after quercetin-rutinoside 14. The excretions in 
the present study were higher, which could be explained by enhanced absorption due to a 
lower dose or to bacterial activity in the colon which is not present in ileostomy patients. 
In a previous study in healthy volunteers 15, the relative excretions were 1.4% after an onion 
rich, and 0.4% after a breakfast rich in quercetin-rutinoside. Thus, in all studies the relative 
excretion of quercetin in urine after onions was higher than after quercetin-rutinoside or 
after tea, which confirms that quercetin from onions is better absorbed. 
Incomplete collection of urine cannot explain the lower absorption of quercetin 
observed after tea. The average recoveries of lithium were in agreement with the expected 
values of 95%. Deviations in sampling by some subjects probably decreased the excretions 
of quercetin after tea, but after correction for incomplete collection the excretion of 
quercetin relative to intake after tea became 0.6% instead of 0.5%. Also, exclusion of the 
data from one subject who became ill during the experiment did not affect the results. 
The excretion of unchanged kaempferol in urine was 2.5% of the amount consumed 
and that of quercetin only 1%. Therefore kaempferol was absorbed better or metabolised 
to a lesser extent than quercetin. 
Utility of the biomarkers 
Epidemiological studies that investigate the relation between intake and disease require 
measurements of long-term intake 16. Flavonol markers probably do not reflect long-term 
flavonol intake. Quercetin and kaempferol accumulate in plasma after repeated intake of 
onions, apples, and tea 15, but the elimination half-life of some 20 h 15 indicates that a 
steady-state concentration in plasma is reached after about 4 days and that plasma 
concentrations would reflect intake of only the last three days. Thus, repeated measurements 
in time may be needed to obtain an estimate that represents the long-term intake. That 
would also reduce the error associated with variations in the interval between blood-
sampling and the most recent intake of flavonol-rich foods. Because of these short-term 
variations we may have missed the quercetin peak concentrations in plasma for onions as 
well for tea 15. 
Whether the use of a biomarker is feasible also depends on the costs of its analytic 
measurements and its stability in stored samples. A method for chemical determination of 
quercetin and kaempferol in plasma was developed by Hollman 22, and can now be 
conducted economically. The maximum decrease in quercetin content of stored plasma 
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samples after one year was about 10% (Hollman; unpublished data). We expect the same 
for plasma kaempferol. Therefore a long interval between sample collection and chemical 
analyses would not be a problem 16. 
Plasma concentrations and urinary excretion of quercetin and kaempferol may also 
be regarded as markers of flavonol status in the body, rather than of flavonol intake. 
Therefore, these levels - when assessing the relation between flavonols and disease - may 
be more directly related with the outcome of disease than intake data. In this way, 
differences in absorption between subjects and bioavailability between dietary sources of 
flavonols are taken into account. 
Conclusion 
We conclude that differences in flavonol intake can be discriminated by the levels of 
quercetin and kaempferol in plasma and in urine. The reproducibility of quercetin levels in 
plasma and urine suggest that these levels can be used as biomarkers to determine quercetin 
intake in epidemiological studies. We also conclude that flavonols from tea are absorbed 
but that the bioavailability of quercetin from tea is only half of that from onions. 
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Abstract 
Flavonols are a major subgroup of the flavonoids, with quercetin and kaempferol as the 
main representatives. Intake of these flavonols may affect health, but it is difficult to assess 
flavonol intake by common record or recall methods. These problems might be overcome 
by use of biomarkers of flavonol intake. Dietary flavonols appear in plasma and urine after 
consumption of flavonol-rich foods. However, the dose-response relationship is as yet 
unknown. Also, no data are available about plasma and urine levels after prolonged intake 
of a diet high in flavonols. We therefore asked 9 subjects to consume a high-flavonol or a 
low-flavonol diet for 4 weeks each, in a cross-over design. The high-flavonol diet provided 
160 mg of flavonols per day. Levels of flavonols in plasma and urine increased 10- to 40-
fold on the high-flavonol diet. Plasma levels of flavonols on this diet were stable from day 
8 until the end of the diet period. The coefficient of variation of repeated measurements 
within subjects was 69% for plasma quercetin and 53% for kaempferol. We combined the 
results obtained after the high-flavonol diet with those obtained after lower intakes in two 
previous studies. Intakes of flavonols up to 132 mg/d were related linearly with their 
concentrations in plasma and excretions in urine. Based on this relationship and the within-
subject variation of the flavonol levels, we conclude that flavonols in plasma and probably 
also in urine can be used as biomarkers to distinguish individuals with a low from 
individuals with a high habitual flavonol intake. These results may facilitate studies on the 
relation between flavonol intake and occurrence of disease. 
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Introduction 
Flavonols are a subgroup of the flavonoids, with quercetin and kaempferol as their major 
representatives in the diet. Flavonols are thought to have beneficial health effects '. 
However, studies that investigated the relationship of flavonol intake with the occurrence 
of coronary heart disease or cancer 2"7 yielded conflicting outcomes 8. One reason for this 
could have been that the recall or record methods used in these studies caused errors in the 
estimation of flavonols 8. Such errors could have attenuated the relative risks observed 9. 
It is difficult to assess flavonol intake accurately because flavonols are concentrated 
in a few foods: tea, onions, apples and red wine account for more than 80% of intake 3. 
This leads to large day-to-day variations in intake 9. Also, errors in the estimation of portion 
sizes of flavonol-rich foods might easily cause individuals to be classified into the wrong 
category of flavonol intakes. A second problem is that the bioavailability of flavonols 
differs between foods. For instance, the bioavailability of quercetin from apples was only 
one-third 10, and that from tea and red wine one-half of that from onions. Thus, recall and 
record methods are probably not the most appropriate methods to measure flavonol intake 
and exposure to flavonols. 
Biomarkers of flavonol intake may overcome some of these problems. Levels of 
flavonols in plasma or urine are potentially valid biomarkers of flavonol intake. In a 
previous study, we found that quercetin and kaempferol levels in plasma and urine reflected 
quercetin and kaempferol intakes from tea or onions consumed for two days. Moreover, the 
measurement error of quercetin levels in plasma and urine was small enough to allow their 
use as biomarkers of quercetin intake. It is likely that levels of flavonols in plasma are 
superior to intake levels for estimating the exposure of target tissues to flavonols in the 
body. This strengthens the case for relating levels of flavonols in body fluids directly to the 
outcomes of disease. 
However, flavonol levels after prolonged or high intakes are as yet unknown, and 
so is the shape of the dose-response curve. This information is needed to assess the 
sensitivity of levels of flavonols to the amount consumed and to assess the variability of 
the flavonol levels. These factors are important to evaluate the suitability of flavonol levels 
as biomarkers of intake. A linear relation between the intake of a nutrient and its biomarker 
improves the suitability of the biomarker to discriminate individuals by their intakes 1112. 
Unfortunately, the intake of nutrients is rarely related linearly with their levels in plasma. 
These levels often show a plateau effect at higher intakes n . An example of such a non-
linear relation is that between vitamin C intake and its level in plasma 12. Another potential 
problem is variability. A large variability of a biomarker within subjects and between days 
indicates that " multiple measurements of the biomarker are required. The objective of this 
study was to evaluate the suitability of flavonols in plasma and urine as biomarkers of 
dietary intake and exposure. To that end, we determined flavonols in plasma repeatedly and 
in urine once after a high dose consumed during a prolonged period. 
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Methods 
Subjects 
We recruited subjects via posters and advertisements in regional papers, and selected nine 
subjects who smoked at least ten cigarettes per day. We selected smokers because another 
aim of this study - the results of which are not presented here - was to determine the effect 
of flavonols on LDL oxidation. The subjects were healthy and had never undergone gastro-
intestinal surgery. They were thoroughly informed about the study, and they filled out and 
signed an informed consent form. The Medical Ethical Committee of the Division of 
Human Nutrition and Epidemiology approved the study. The mean age (± SD) of the 
subjects was 33 ± 17 y and their mean body mass index was 23 ± 4 kg/m2. 
Protocol 
The study lasted 52 days and consisted of a test and control period of 26 days each, in a 
cross-over design. During the whole study the subjects followed a background diet low in 
flavonols. This diet was also restricted in vitamin C because high vitamin C intakes might 
have interfered with the sub-study on LDL oxidation. The subjects received flavonol-rich 
supplements in the test period, but received no supplements in the control period. 
The subjects were not allowed to use medications except for oral contraceptives and 
paracetamol. They recorded all deviations from the guidelines in a diary, and they recorded 
their food intake in each period for 3 days. According to these records, flavonol intake from 
the background diet was 1 ± 1 mg/d. 
Supplements 
On each day of the high-flavonol period the subjects consumed four types of flavonol-rich 
supplements. These were 160 grams of fried onions, 220 grams of applesauce enriched with 
20 grams of freeze-dried apple-peels, 6 cups of tea, and 1 piece of apple. The onions and 
the freeze-dried apple peels were prepared prior to the study. Yellow onions from a single 
batch were fried for nine minutes, mixed, weighed out in portions of 160 grams in 
aluminium trays, and stored at -20° C. Jonagold apples were peeled and the peels were cut 
and freeze-dried: one kg of apple peels yielded 186 grams of freeze-dried powder. This 
powder was added to applesauce (Jonker Fris). To prepare one cup of tea, subjects added 
boiling water to 0.5 g of tea-extract. They consumed the piece of apple (Jonagold) with the 
peel. 
The subjects came to our department three times a week to collect the supplements. 
They consumed the supplements distributed over the day at a time they preferred, except 
on days that blood was sampled. On these days, the subjects were asked to consume the 
applesauce, the apple, and three cups of tea before noon, and the onions and the remaining 
three cups of tea after blood sampling. In this way, short-term effects of consumption on 
plasma concentrations were standardized. 
We took duplicate samples of the supplements and analyzed them for quercetin, 
kaempferol, and isorhamnetin as described l3. The total intake of quercetin (± SD) was 132 
± 4, of kaempferol 22 ± 2, and of isorhamnetin 6 ± 0 mg/d. Onions contributed the largest 
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amount of quercetin (Figure 5.1), and tea the largest amount of kaempferol. Onions and 
apples contributed equally to the intake of isorhamnetin. 
Onions 
47.6% 
Apple 
3.8% 
Applesauce+peels 
24.4% 
Onions 
1.8% 
Ap\Jesauq4+peels 
Apple 
0.5% 
Quercetin Kaempferol 
Figure 5.1 Contribution of the various supplements to the intake of quercetin and 
kaempferol on the high-flavonol diet. The total intake of quercetin on this diet was 132 mg 
and of kaempferol 22 mg per day. 
Sampling of blood and urine 
Blood and urine were sampled during each period, and plasma concentrations and urinary 
excretion of flavonols were analyzed after the study. Venous blood samples were taken as 
described 10 between 14.00 and 15.00 pm on days 8, 15, 25, and 26 of each period. Urine 
samples were collected on day 25 of each period by the subjects in bottles that contained 
thymol dissolved in isopropanol as a preservative. The first urine voiding after rising in the 
morning was discarded. All subsequent urines until the first urine after rising the next 
morning were collected and immediately put on dry ice. Within one to five days the urines 
were thawed at 40° C, pooled per subject per day, and aliquots were stored at -40°C until 
analyses. Completeness of urine collection was checked by assessment of recovery in urine 
of 250 (.imol of lithium. It was taken by the subjects as 10.6 mg of lithium chloride 
dissolved in 10 ml water from day 19 until day 26 of each period. This dose is 1% of that 
considered safe for chronic use in patients with bipolar disorders. The recovery in urine of 
orally ingested lithium is about 95% 14,15. The average lithium recovery in our study was 
higher; it was 105 ± 5% (n=8) in the control, and 99 ± 11% (n=9) in the test period. Eleven 
out of 17 measured values of lithium in urine were within 10% of the expected value of 
95%. Five values indicated that too much and one that too little urine had been collected. 
These urine values were corrected for lithium recovery. 
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Analytical methods 
Quercetin, kaempferol, and isorhamnetin were simultaneously extracted and hydrolysed to 
the aglycone using 2 M HC1 in aqueous methanol 16, and determined by HPLC with 
fluorescence detection n . The limit of detection was 2 \ig/L for quercetin in plasma and 3 
Hg/L for that in urine, and 1 ^g/L for kaempferol and isorhamnetin in plasma as well as 
urine. Lithium was analyzed in a separate undiluted acidified urine sample by atomic 
absorption spectrophotometry 18. 
Statistical analyses 
We performed statistical analyses with SAS 19. We calculated the mean of the four plasma 
concentrations of flavonols on the low flavonol diet and the mean on the high flavonol diet 
for each subject, and the average difference between these for the nine subjects. We 
investigated the variability of flavonol concentrations in plasma between the four blood 
samples by analysis of variance (PROC ANOVA). After converting the amounts of 
flavonols in plasma levels to 10log values, we used PROC VARCOMP to determine the 
within- and between-subject variances as components of total variability in plasma. In 
addition, we determined Pearson correlation coefficients; we calculated their confidence 
intervals using Fisher's Z transformation. 
We used additional data from two previous studies to determine how the intake of 
quercetin and kaempferol was related with their levels in blood and urine. In the first study 
15 men and women consumed black tea providing 49 mg quercetin and 27 mg kaempferol, 
or fried onions providing 13 mg of quercetin and no kaempferol, both for two days. In the 
second study, 12 men consumed red wine, fried onions, or black tea providing about 15 mg 
of quercetin each. In addition the wine provided 1.5 mg kaempferol and the tea 9 mg of 
kaempferol. The wine, the onions, and the tea were each taken for 4 days. We determined 
the regression equations and the 95% confidence intervals (CI) for the regression 
coefficients of doses of flavonols on responses of plasma or urine levels using the combined 
results of the previous studies and the present study. 
Results 
Levels after a prolonged high intake 
Both the concentrations of flavonols in plasma and the excretions in urine were clearly 
higher on the high-flavonol than on the low-flavonol diet (Figure 5.2). These levels 
increased 30- to 40-fold for quercetin, 20- to 25-fold for kaempferol, and 10- to 15-fold for 
isorhamnetin. The differences in plasma concenteations between the high-flavonol and low-
flavonol diet were 96 ± 50 yig/L for quercetin, 15 ± 7 |ig/L for kaempferol, and 10 ± 8 
Hg/L for isorhamnetin (means ± SD;n=9);Figure 5.2A). The differences in 24h-urinary 
excretions of flavonols between the two diets were 921 ± 400 ng/d for quercetin, 
434 ± 145 ng/d for kaempferol, and 217 ± 124 u,g/d for isorhamnetin (Figure 5.2B). 
Urinary excretion as a percentage of the amount consumed was on average 0.7 ± 3% for 
quercetin, 2.1 ± 0.8% for kaempferol, and 4.0 ± 2.4% for isorhamnetin. 
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Figure 5.2 The effects of the intake of 132 mg quercetin, 22 mg of kaempferol, and 6 mg 
of isorhamnetin on concentrations of these flavonols in plasma (2A) and excretions in 24-
hour urine (2B) of nine volunteers. Each diet period lasted 26 days. 
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Figure 53 The dose-response relationship between quercetin intake and mean levels in 
plasma and urine across studies. Data are from two previous studies that investigated the 
effects offlavonol intakes from single flavonol-rich foods, and from the present study, which 
investigated the effect of a high flavonol intake from a combination of flavonol-rich foods. 
Each point represents the mean and SD of 12 (*•), 15 (+), or 9 subjects (•) 
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Dose-response relationship 
Flavonol intake was related linearly with flavonol concentration in plasma and with 
excretion in urine (Figures 5.3 and 5.4). Figure 5.3 shows the mean plasma levels and 
urinary excretions of quercetin in the present and previous studies as a function of intake. 
Figure 5.4 shows the same data for kaempferol. The equations and 95% confidence 
intervals describing the relations of plasma and urinary quercetin and kaempferol with the 
amounts consumed are presented in Table 5.1. 
Table 5.1 Equations describing the relation of levels of flavonols in plasma and urine (Y) 
with their intake (X) 
Flavonol levels 
Plasma quercetin [xg/L 
Urinary quercetin ng/24h 
Plasma kaempferol (J.g/L 
Urinary kaempferol ng/24h 
" X = intake of quercetin (mg/d) 
f
 X = intake of kaempferol (mg/d) 
Number of 
observations 
36 
36 
36 
36 
Regression 
equation 
Y = 2.2 + 0.7 X* 
Y = 3.4 + 7.2 X* 
Y = 0.4 + 0.6 X+ 
Y = 24.7 + 22.4 X+ 
95% Confidence 
interval for the 
regression 
coefficient 
0.6;0.9 
5.9;8.6 
0.4;0.8 
17.5 ;27.3 
Variability 
Concentrations of quercetin and kaempferol in plasma differed little between the four blood 
samples obtained on the high-flavonol diet. No significant differences (p<0.05) between 
concentrations of these samples were found. Therefore, concentrations of total flavonols in 
plasma were stable with time. The coefficient of variation within subjects of the levels in 
the four blood samples obtained on the high-flavonol diet was 32% for quercetin, and 53% 
for kaempferol. The coefficient of variation between subjects was 61% for quercetin, and 
18% for kaempferol. 
The correlation between plasma concentrations and urinary excretions was better for 
quercetin than for kaempferol: the Pearson correlation coefficient between the average 
plasma concentrations on days 25 and 26 on the high-flavonol diet and the excretion in 
urine on day 25 was 0.66 (CI 0.01 ;0.92) for quercetin, and 0.32 (CI -0.44;0.81) for 
kaempferol. Plasma concentrations of quercetin appeared to be related to those of 
isorhamnetin. The correlation coefficient between these plasma concentrations was 0.78 (CI 
0.24;0.95). 
58 Chapter 5 
._..^ flav£ 0
 diet 5 10 15 20 
Intake, mg/day 
25 30 
1,200 
_ 1 
If 
<M 
3 . 
O 
e 
CD 
(0 
(0 
c 
, 0 0 0 -
8 0 0 -
6 0 0 -
4 0 0 -
200 
tea 
high-flavonol diet 
tea 
wine 
low-flav6nol Odiet 5 10 15 20 
Intake, mg/day 
25 30 
Figure 5.4 The dose-response relationship between kaempferol intake and levels in plasma 
and urine. Data are from two previous studies investigating the effects of low-flavonol 
intakes from single flavonol-rich foods, and from the present study investigating the effect 
of high-flavonol intakes from multiple flavonol-rich foods. Each point represents the mean 
and SD of 12 (*), 15 (+) or 9 subjects (•) 
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Discussion 
The objective of this study was to evaluate the suitability of flavonol concentrations in 
plasma and flavonol excretions in urine as biomarkers of flavonol intake. The major 
conclusion of our study is that the concentration of quercetin in plasma can be used to 
distinguish individuals with a low from those with a high intake of quercetin. We base this 
conclusion on an evaluation of flavonol levels with respect to two factors. These factors are 
their sensitivity to intake, and their variability. We will discuss both factors in more detail 
below. 
Sensitivity to intake 
An important prerequisite of a biomarker is that it is sensitive to intake. In addition to this, 
it is important to know the shape of the relationship between intake of the nutrient and the 
level of the biomarker. 
Concentrations of flavonols in plasma and excretions in urine appeared to be 
sensitive to their intake. This was shown by the fact that levels of quercetin and kaempferol 
were clearly higher on the high-flavonol than on the low-flavonol diet. In addition, flavonol 
excretions in urine on the high-flavonol diet agreed well with those observed previously 10, 
after consumption of single foods, if type and dose of food were taken into account. As 
urinary excretion predicts bioavailability of flavonols 10, this implies that the bioavailability 
was not influenced by the dose or by prolonged consumption. We will illustrate this with 
the following calculation. In the high-flavonol diet, onions contributed 63 mg, tea 32 mg, 
and apples 37 mg to quercetin intake. In studies of single foods, urinary excretion of 
quercetin was 1.0% of the amount consumed from onions, 0.5% of the amount consumed 
from tea, and 0.3% of the amount consumed from apples I0,2°. The predicted excretion on 
the high-flavonol diet therefore is 1.0% of 63 mg + 0.5% of 32 mg + 0.3% of 37 mg = 0.90 
mg/d, which equals 0.7% of the total intake of 132 mg. This value is identical to that 
observed. For kaempferol, it was also clear that bioavailability was not influenced by the 
dose (Figure 5.4B): a constant percentage was excreted over a wide range of intakes. These 
findings point to a linear relationship between intake of flavonols and their excretion in 
urine. This was confirmed by the combined results of the present study and the two 
previous studies. These showed that intake of flavonols was related linearly with their 
concentrations in plasma and their excretions in urine within the range of normal intakes 
(Figure 5.3 and 5.4). Small deviations from the regression lines for quercetin could be 
explained by differences in bioavailability between the foods: levels after onions were 
above and after tea below the regression lines. Thus, levels of flavonols in plasma and urine 
were sensitive to intake within the habitual range of consumption i,n. 
Variability 
The variability of a biomarker should not be too large, because variability leads to 
misclassification when individuals are classified by their intake 9. Information about 
variability can be obtained by observing the levels of biomarker in time, and by calculating 
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the coefficient of variation within subjects after repeated measurements. 
Plasma levels of flavonols stabilized within one week on the high-flavonol diet. This 
was evidenced by the fact that plasma concentrations of flavonols did not change beyond 
day 8. The level of quercetin on day 8 on the high flavonol diet was somewhat higher than 
that on day 15, but this was probably by chance. Stable plasma levels beyond day 8 agree 
with the half-live of 24 h with which quercetin is eliminated from the body 10. A half-live 
of 24 h indicates that after repeated intakes of quercetin-rich foods quercetin in plasma 
reaches 87.5% of its plateau level after 3 days. Thus, it is to be expected that plateau levels 
of quercetin in plasma and probably also of kaempferol are reached between three and 
seven days after the start of repeated consumption. 
Variability of the level of a biomarker is caused by within-subject variations, 
metabolic between-subject variations, and imprecision in the laboratory. We determined 
these components of variability for quercetin from the four repeated measurements in 
plasma on the high-flavonol diet. The within-subject coefficient of variation for quercetin 
was 32%, and the between-subject coefficient of variation was 61 %. These coefficients of 
variation include imprecision in the laboratory. Therefore, the total coefficient of variation 
for a single measurement of quercetin in plasma between individuals with the same intake 
was \/(322 + 612)= 69%. This coefficient of variation is larger than that of 30% which we 
found for plasma quercetin in a previous study after a lower dose of quercetin from 
onions 20. When we left the data of one subject with the lowest urinary excretion out of the 
analysis, the coefficient of variation decreased to 52%. This subject probably did not 
consume all the supplements, because his excretion was 0.3% lower than the lowest level 
seen in a previous study 20. Nevertheless, the value of 52% is still higher than the value of 
30% found before. This larger variation may be explained by the higher dose, the longer 
period, an intake from more than one food source, or by chance. Also, heavy smoking 
might have increased differences in metabolism between subjects in this study 22. For 
subsequent calculations of practical consequences we use the variation coefficient of 52%. 
Applicability of plasma quercetin in epidemiological studies 
Biomarkers of intake can be used to classify individuals into categories of intake. Therefore, 
we calculated what differences in quercetin intake might be discriminated when plasma 
quercetin is used as a biomarker. For these calculations we used the formula b=(Zpa//n) 
and a probability of misclassification of 0.05 23. In this formula, b denotes the distance 
between the true mean flavonol intake for an individual and the boundary point between 
a higher and a lower class of intake, Zp the percentage point of the standard normal 
distribution, o the measurement error, and n the number of measurements. We calculated 
the measurement error of the plasma quercetin, o, for an average intake of 16 mg/d 3. The 
equation: plasma quercetin = 2.2 + (0.7 x quercetin intake) (Table 5.1) then predicts a 
plasma level of quercetin of 13 ng/L. 52% of 13 \xg is 7 ng/L; thus o= 7 Lxg/L. This value 
of 7 (xg/L when included in the formula results in a difference in flavonol intake of 14 mg 
per day. Thus, when the upper boundary point of a lower quantile differs 14 mg or more 
from the lower boundary point of a higher quantile, the probability for an indivual to be 
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misclassified from the lower quantile to the higher quantile or conversely by one 
measurement of plasma quercetin is < 0.05. According to recent studies 3,5,f''24 differences 
observed between the lowest and the highest quantile of quercetin intake vary between 20 
and 30 mg/d; therefore subjects with a low or with a high flavonol intake could be easily 
distinguished by one measurement of quercetin in plasma. In the Health Professional 
Study 6 the difference between the medians of flavonol intake of the third and fifth quintile 
was 18 mg/d of quercetin. In the Zutphen Study 2, the highest intake of the lowest fertile 
differed 11 mg/d from the lowest intake of the highest tertile. Thus, these two studies 
indicate that one or two plasma samples are sufficient to distinguish individuals at least by 
low and high flavonol intakes. 
In cross-cultural studies, differences in quercetin intake between individuals might 
be larger than in cross-sectional studies. In the Seven-Countries Study 4 the difference in 
quercetin intake between the cohort with the lowest intake (West-Finland) and the highest 
intake (Ushibuka, Japan) was 33 mg/d. In a group of subjects from a variety of countries 
21
, we found differences in intake of more than 50 mg/d. Thus, in these studies a larger 
number of quantiles could be distinguished than in one population. 
Levels of other flavonols 
In addition to quercetin in plasma, quercetin in urine and kaempferol in plasma or urine 
could probably also be used as biomarkers of intake. As excretion of quercetin in urine 
agreed reasonably well with concentration in plasma urinary (Figure 5.3) excretion may also 
be a suitable biomarker of quercetin intake. However, we were not able to determine the 
within-subject variation because measurements in urine had not been repeated. It was also 
not possible to assess the suitability of habitual kaempferol in plasma or in urine as 
biomarkers of their intake, because variation of kaempferol intake between free-living 
subjects was not known. Also, the role of isorhamnetin is not yet clear. Levels of 
isorhamnetin may be used in addition to those of quercetin to determine quercetin intake, 
as it is formed from quercetin in the body. This relationship was confirmed by a correlation 
coefficient of 0.78 between plasma levels of quercetin and isorhamnetin. 
Conclusions 
We found that intake of flavonols is related linearly with their levels in plasma and urine. 
Because of this relation, and because variability of plasma levels is limited, plasma 
quercetin can be used to classify individuals into categories of quercetin intakes. Therefore, 
flavonol biomarkers may be a valuable tool to assess flavonol intake in epidemiological 
studies. 
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Abstract 
Specific fatty acids and sterols in food composites from seven countries were analyzed. In 
the 1960s, groups of 8 to 49 men from 16 cohorts, ages 40 - 59 y and living in the United 
States, Finland, the Netherlands, Italy, Greece, the former Yugoslavia, or Japan recorded 
their food intake. In 1987, we collected food composites representing the average food 
intake per cohort sample in the 1960s. The foods were transported to the Netherlands, 
pooled, and centrally analyzed for energy, total fat, 42 fatty acids, cholesterol, and four 
plant sterols. The fat content ranged from 12% of total daily energy in the Tanushimaru, 
Japan, cohort to 50% in the US cohort sample, and the polyunsaturated to saturated fat ratio 
from 0.17 in the East-Finland cohort to 1.2 in Tanushimaru. The amount of trans fatty acids 
with 16 or 18 carbon atoms varied between 0.2 g/day in Corfu, Greece and 8.6 g/day in 
Zutphen, Netherlands, and that of a-linolenic acid between 0.8 g/day in Rome and 2.5 
g/day in east Finland. The sum of eicosapentaenoic (EPA) and docosahexanoic acid (DHA) 
ranged from 0.1 (U.S. railroad) to 2.0 g/day (Ushibuka, Japan), and phytosterols from 170 
(US railroad) to 358 mg/day (Corfu, Greece). Thus the intake of various fatty acids and 
sterols with potential relevance for coronary heart disease occurrence varied 10-fold or more 
between cohorts. Our data can be used to generate new hypotheses about the causes of 
differences in incidence of diseases between countries. 
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Introduction 
Fatty acids and sterols in the diet play a major role in the etiology of coronary heart 
disease '.Therefore, it is important to know the amounts and types of fatty acids and sterols 
that are present in the diets of populations, and to know which foods are the main 
contributors. However, food tables lack reliable data on the content of specific fatty acids, 
such as trans fatty acids 2, long chain polyunsaturated (n-3) fatty acids, and plant sterols. 
As a consequence, the content of these nutrients in diets cannot be calculated from food 
balance sheets or dietary surveys, using nutrient data bases. 
At the end of the 1950s, the Seven Countries Study was designed to study the 
relationships between diet and the occurrence of chronic diseases 3. The food intake was 
recorded at that time by random samples of men, ages 40 - 59 years, who were part of a 
total of 16 cohorts in the United States, Finland, the Netherlands, Greece, Italy, the former 
Yugoslavia, and Japan. Duplicate portions were collected in 1960, and protein, total fat, and 
overall fatty acid composition were analyzed. However, a large number of nutrients and 
other components in the diet which could be important with regard to the occurrence of 
diseases were not determined. In 1987 we therefore decided to sample equivalent food 
composites, representing the average reported food intake of the men in the 1960s ",5, and 
to analyze these chemically for a large number of nutrients and nonnutrients. 
One of our aims was to obtain detailed information on the fatty acid and sterol 
composition of the diets, and we therefore determined the mean content of 42 fatty acids 
and four sterols in the collected food composites in a central laboratory. We present here 
the results of these chemical analyses, which can be used to investigate relationships 
between the composition of diets in the 1960s and the disease outcome in later years. 
Methods 
Subjects 
Sixteen groups each containing 502 to 2571 men, ages 40-59 years, were selected in the 
seven countries. Random samples of 8 to 49 men in each cohort (Table 6.1), recorded their 
food intake, mostly during seven days at the baseline survey in the 1960s 4"6. 
The US participants were railroad employees. One Finnish cohort lived in east 
Finland, and the other in west Finland. In the Netherlands men living in the commercial 
town of Zutphen, in the eastern part of the country, participated. Italy contributed three 
cohorts: Montegiorgio and Crevalcore, both rural villages, and railroad personnel in Rome. 
Greece contributed two: one on Crete and one on the island of Corfu. Five cohorts were 
from the former Yugoslavia: two from Croatia included inhabitants of six towns on the 
Dalmatian Coast and of Dalj, a small town in Slavonia. The other three cohorts consisted 
of farmers from the village of Velika-Krsna, workers in a large cooperation in Zrenjanin, 
and university professors in Belgrade in Serbia, respectively. Japan had two cohorts: 
farmers from the village of Tanushimaru and fishermen from the village of Ushibuka. 
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Table 6.1 Characteristics of food records reported by men ages 40 to 59 years in 16 
cohorts in seven countries in the 1960s 
Cohort 
US railroad 
East-Finland3 
West-Finland" 
Zutphen 
Crevalcore" 
Montegiorgio" 
Rome railroad 
Corfu"" 
Crete"" 
Dalmatia 
Slavonia" 
Belgrade" 
Velika-Krsna" 
Zrenjanin" 
Tanushimaru" 
Ushibuka" 
Country 
United States 
Finland 
Finland 
Netherlands 
Italy 
Italy 
Italy 
Greece 
Greece 
Croatia 
Croatia 
Serbia 
Serbia 
Serbia 
Japan 
Japan 
Year 
1960-62 
1959 
1959 
1960 
1960 
1960 
1969 
1961-63 
1960-65 
1960 
1960 
1964 
1963 
1963 
1964 
1971 
Number of 
subjects 
30 
30 
30 
45 
29 
35 
49 
37 
31 
24 
24 
41 
21 
40 
24 
8 
Number of 
recording days 
1 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
7 
4 
Note The full cohorts contained 502 to 2571 men, of whom a random sample or 8-49 recorded their food 
intake ' Food recorded as amounts of raw products h Original records no longer available 
Food records 
Between 1959 and 1964 samples of participants from 13 cohorts recorded and weighed all 
they ate and drank for 7 days and a sample of U.S. railroad employees did the same for 1 
day. The participants from Rome recorded their food intake in 1969 for 7 days and those 
from Ushibuka in 1971 for 4 days. Thirteen cohorts reported the foods as weight of edible 
parts of raw products, and three cohorts as prepared foods. The two Greek cohorts recorded 
their intakes in different seasons. As the original 7-day records of the Greek cohorts were 
no longer available, we reconstructed the diets using a publication of Keys 5, and 
information provided by the Greek dietician involved in the original study. We derived 
missing information on some foods, especially fruits and vegetables, from food balance 
sheets of Greece from the period 1961-65 7. 
Food composites 
In 1986, the food intake data were recoded in a standardized way by one dietician. We 
converted amounts of prepared into amounts of raw foods, taking into account loss of water 
and loss and gain of fat during cooking. For each cohort sample, we averaged the daily 
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consumption of each food across persons and collected this amount. 
Two Dutch dieticians assisted by local researchers and co-workers from the Seven 
Countries Study bought all foods between April and October 1987 in the same regions in 
which the men were living during the baseline survey in the 1960s. In 10 of the 16 
locations they bought the duplicates in the same season (± 2 months) during which the food 
intakes had been recorded. For the United States, Belgrade, Zrenjanin, and Tanushimaru the 
purchasing of the foods took place in a different season. 
The fat compositions of foods have changed between the 1960s and 1987 8, and 
therefore we had to select the food items carefully to approximate the composition of the 
foods as consumed by the men in the 1960s as near as possible. For this purpose, we used 
food composition tables, and data from the literature 4. The major food groups contributing 
to the fat composition of the diets were meat, dairy products, edible fats and pastries. For 
meat, we often chose the fatter variants (Table 6.2). We reduced the quantity of products 
to be bought by combining foods. We substituted foods consumed in amounts of less than 
10 g per day by foods consumed in higher amounts, with a similar nutrient composition. 
In Table 6.2, we show the substitutions made for meat. If a food was no longer available 
locally, we also used a substitute with a comparable composition. Detailed information on 
the food sampling has been described in a Dutch report 9. The maximum number of 
different foods bought per cohort was 80. The dieticians vacuum-packed all foods in plastic 
bags, and sent them to the Netherlands in cooled boxes by air express. 
The average period between acquiring the foods and their first workup in the 
laboratory was 2 days (range 1-4 days). Inedible parts were removed so as to produce the 
edible part as recorded and consumed in the 1960s. For example, we only peeled apples if 
that is how they were consumed originally. Thereafter, the foods were weighed out, and 
homogenized at the Department of Human Nutrition, Agricultural University Wageningen. 
Foods were divided into subsamples before homogenizing. Homogeneous foods present in 
relative big amounts were blended together into a main sample after adding of t-BHQ (500 
mg/kg). Nonhomogeneous foods or products present in small amounts were blended into 
a subsample first. The sizes of these subsamples were scaled up 5-50 times from the 
original amount. After that a proportional amount of the subsample separate was added to 
a part of the main sample. Foods containing vitamin C were also blended in separate 
subsamples containing 2% oxalic-acid. If a sample was too dry to homogenize, a known 
amount of demineralized water was added. After homogenization, the final combined 
samples were stored at -20°C. 
Chemical analyses 
We determined the amount of total fat according to Folch et al. 10. The fatty acids were 
assayed after saponification of the Folch extract and derivatization to methyl esters n . Fatty 
acids were analyzed by three different methods, on a Chrompack 438AS gas chromatograph 
equipped with a flame ionization detector. For determination of C8, C10, C12, C14, C14:l, 
C15, C16, C16:l, C17, C17:l, C18, C18:l, C18:2, C18:3(n-6), C18:3(n-3), C20, C20:l, and 
C20:2, the column was a Durabond-225 fused silica, length x internal diameter 15m x 
T
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0.54mm. The flow rate of the carrier gas hydrogen was 7.5 ml/min. The oven temperature 
was programmed from 100 to 180°C at a rate of 10°C/min, then to 225°C at 4°C/min, 
which was maintained for a further 2.75 min before cooling. The injector temperature was 
220°C, and 0.5 yd was injected directly into a modified liner. The detector temperature was 
250°C, the hydrogen flow for the detector was reduced to 17.5 ml/min, and the flow rate 
of the make-up gas nitrogen was 25 ml/min. 
Trans fatty acids were determined by gas chromatography in our laboratory, and 
these results were checked by gas chromatography, and Fourier transform infrared 
spectrometry in the research laboratory of the Raisio group at Raisio, Finland. The trans 
fatty acid content of the food composite of Zutphen could not be analyzed in Finland due 
to solvent in the sample, and therefore it was re-analyzed by Fourier transform infrared 
spectrometry in our own laboratory together with the food composites of east and west 
Finland, and Velika-Krsna. The geometric and positional isomers of C16:l, C18:l, and 
C18:2 fatty acid methyl esters were measured using a CP-S088 fused silica 50-m x 0.25-
mm column (Chrompack, the Netherlands). The oven temperature was programmed from 
160°C to 220°C at a rate of 2°C/min plus 5 min at 220°C. The carrier gas was hydrogen, 
and the inlet pressure was 130 kPA. The injector was a splitter with a split ratio of 1:60, 
and a volume of 0.5 [xl was injected at a temperature of 250CC. Fourier transform infrared 
spectrometry in Wageningen was done using a Biorad Digilab Division, Type FTS-7 
infrared spectrophotometer. The preparation of fatty acid methyl esters for gas 
chromatography in Finland was done according to Bannon et al n, and for the infrared 
spectrometry method according to IUPAC 2.301. Duplicate esters of the samples were 
analyzed as neat solutions according to Sleeter and Matlock ' \ For gas chromatography in 
Finland a Hewlett-Packard 5890 II was used, and the IR spectrophotometer was a Perkin-
Elmer 16PC, Type FTIR. 
The fatty acids C18:4(n-3), C22, C22:l(«-9), C20:3(«-3), C20:4(n-6), C24, C20:5(«-
3), C24:l, C22:3(/t-3), C22:4(«-6), C22:5(«-3), and C22:6(«-3) were assessed separately in 
a third analysis, again using a CP-Sil88 fused silica 50-m x 0.25-mm column. The initial 
oven temperature was 160°C for 4 min, followed by a rise of 25°C/min to 215°C, which 
was kept for a further 12 min before cooling down. The injector was a Splitter with a split 
ratio of 1:15, and the injected volume was 1.5 jxl. Injector and detector temperature were 
250°C. 
We extracted the unsaponifiable part of the lipid 14 and determined cholesterol, 
campesterol, stigmasterol and C-sitosterol by gas chromatography using a Chrompack-
Packard model 439, column CP-Sill9/cb (25 m x 0.25 mm). The oven temperature was 
programmed from 240 to 265°C at a rate of 1.25 °C/min, then to 285°C by 5°C/min, which 
was maintained for a further 8 minutes before cooling down. The carrier gas hydrogen had 
an inlet pressure of 105 kPa. The injector was a splitter, and the injected volume 1 LII with 
a split ratio of 1:30. The temperature of injection was 300°C and of detection 305 °C. The 
flow rate of the make-up gas nitrogen was 25 ml/min. We determined response factors by 
injection of pure compounds with 5ct-cholestane as internal standard. For campesterol we 
used the factor for cholesterol. Chromatograms for fatty acids and for sterols were recorded 
by a personal computer equipped with PCI-GC software version 4.0 (Chrompack). 
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We tested the recovery of n-3 fatty acids by adding herring of known EPA and DHA 
content to 1766 grams of the food composite of Zutphen. Recovery was 106 ± 5% for 
C20:5 and 98 ± 6% for C22:6 after addition of 11 g, and 93 ± 5% for C20:5 and 88 ± 4 
% for C22:6 after addition of 25 g of herring. 
The conversion factor used for fat to fatty acids was 0.956. We determined protein 14 and 
alcohol 15 and calculated carbohydrates as the sum of analyzed values of galactose, glucose, 
saccharose, lactose, maltose and starch. Atwater factors for the calculation of energy were 
17 kJ (4 kcal) for protein, 37 kJ (9 kcal) for fat, 16 kJ (3.75 kcal) for carbohydrates, and 
29 kJ (7 kcal) for alcohol. 
Calculation by use of food composition tables 
We compared the analyzed values for the food composites from the United States, Finland, 
the Netherlands, and Italy with values calculated using food composition tables. We used 
the Dutch computerized nutrient data bank 16 for foods with a nutrient composition similar 
to that of Dutch foods and for foods containing no fat or sterols, and the food composition 
table of the specific countries 17'19 for the remainder. 
Table 6.3 Total energy and fat content and major classes of fatty acids, determined by chemical analysis of 
food composites reflecting the average recorded food intake of samples of middle-aged men living in 16 
cohorts in seven countries in the 1960s 
Cohort 
US railroad, USA 
East-Finland 
West-Finland 
Zutphen, Netherlands 
Crevalcore, Italy 
Montegiorgio, Italy 
Rome railroad, Italy 
Corfu, Greece 
Crete, Greece 
Dalmatia, Croatian 
Slavonia, Croatian 
Belgrade, Serbia 
Velika-Krsna, Serbia 
Zrenjanin, Serbia 
Tanushimaru, Japan 
Ushibuka, Japan 
Energy 
MJ/d 
9.6 
14.4 
14.7 
11.3 
15.2 
12.1 
11.0 
11.3 
11.8 
15.8 
15.5 
11.4 
14.3 
13.4 
10.0 
10.2 
Total fat 
gld 
131 
166 
142 
137 
155 
101 
96 
105 
131 
148 
179 
143 
115 
149 
33 
46 
% of energy 
50 
42 
36 
45 
38 
31 
32 
34 
41 
35 
43 
46 
30 
41 
12 
17 
SFA 
55 
89 
73 
61 
54 
31 
28 
22 
28 
40 
69 
57 
52 
55 
10 
14 
MUFA 
gld 
49 
55 
49 
50 
73 
50 
54 
63 
84 
78 
81 
54 
42 
65 
10 
17 
PUFA 
21 
15 
14 
20 
21 
15 
10 
15 
13 
24 
22 
26 
16 
23 
12 
13 
P/S 
ratio 
0.4 
0.2 
0.2 
0.3 
0.4 
0.5 
0.4 
0.7 
0.5 
0.6 
0.3 
0.4 
0.3 
0.4 
1.2 
0.9 
J
 SFA, saturated fatty acids; MUFA. monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; P/S ratio = ratio of polyunsaturated 
to saturated fatty acids. 
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Results 
Energy and total fat 
The energy content varied from 9.6 MJ/day in the diets of the US railroad employees to 
15.8 MJ/day in the Croatian cohort Dalmatia, and the fat content in the food composites 
from 12% of total energy in the Japanese farmers in Tanushimaru to 50% in the USA 
(Table 6.3). The ratio of polyunsaturated to saturated fatty acids (P/S) varied from 0.2 for 
east and west Finland to 0.9 and 1.2 for Ushibuka and Tanushimaru in Japan, respectively 
(Table 6.3). 
Saturated fatty acids 
The saturated fatty acid content was low (<10% of energy) in the food composites of 
Greece and Japan, the Italian cohorts Montegiorgio and Rome, and the Croatian cohort 
Dalmatia. We found high levels of saturated fatty acids (>15% of energy) for east and west 
Finland, the Netherlands, the United States, the Serbian cohorts Belgrade and Zrenjanin, and 
the Croatian cohort Slavonia. 
Table 6.4 Saturated fatty acids in food composites from 16 cohorts of middle-aged men in seven countries, 
representing the average food intake in the 1960s, sampled in 1987 
Cohort 
US railroad, USA 
East-Finland 
West-Finland 
Zutphen, Netherlands 
Crevalcore, Italy 
Montegiorgio, Italy 
Rome railroad, Italy 
Corfu, Greece 
Crete, Greece 
Dalmatia, Croatian 
Slavonia, Croatian 
Belgrade, Serbia 
Velika-Krsna, Serbia 
Zrenjanin, Serbia 
Tanushimaru, Japan 
Ushibuka, Japan 
C8:0 
0.5 
1.3 
0.4 
0.6 
0.5 
0.1 
0.2 
0.2 
0.3 
0.3 
0.2 
0.7 
0.9 
0.1 
0.1 
0.0 
C10:0 
1.3 
3.3 
2.1 
1.3 
0.8 
0.3 
0.4 
0.4 
0.7 
0.5 
0.5 
1.2 
1.3 
0.3 
0.0 
0.0 
C12:0 
1.8 
4.3 
3.4 
2.2 
1.1 
0.3 
0.7 
0.3 
0.5 
0.5 
0.6 
1.3 
1.5 
0.4 
0.1 
0.2 
C14:0 
5.8 
14 
11 
8.0 
4.2 
1.3 
2.4 
1.1 
1.8 
2.5 
3.7 
5.6 
5.8 
2.6 
0.8 
1.0 
C15:0 C16:0 
grams per day 
0.7 
1.6 
1.1 
0.8 
0.5 
0.1 
0.3 
0.2 
0.3 
0.3 
0.5 
0.8 
0.8 
0.2 
0.1 
0.1 
30 
41 
35 
30 
31 
19 
17 
16 
18 
24 
42 
31 
29 
33 
6.5 
9.2 
C17:0 
0.7 
0.9 
0.7 
0.6 
0.5 
0.3 
0.3 
0.1 
0.2 
0.4 
0.5 
0.7 
0.5 
0.5 
0.1 
0.2 
C18:0 
14 
22 
18 
15 
15 
9.4 
6.2 
3.1 
5.6 
10 
20 
15 
12 
17 
2.0 
3.0 
C20:0 
0.3 
0.4 
0.3 
1.0 
0.5 
0.3 
0.3 
0.4 
0.6 
0.5 
0.2 
0.4 
0.1 
0.4 
0.1 
0.1 
C22:0 
0.3 
0.3 
0.4 
1.1 
0.4 
0.2 
0.2 
0.2 
0.3 
0.3 
0.2 
0.4 
0.2 
0.2 
0.1 
0.1 
C24:0 
0.1 
0.1 
0.2 
0.5 
0.2 
0.1 
0.1 
0.1 
0.1 
0.2 
0.1 
0.2 
0.1 
0.1 
0.1 
0.1 
The levels of the medium chain fatty acids (MCT) caprylic (C8:0) and capric acid 
(C10:0) were high in the Finnish samples (Table 6.4). The contribution of lauric (12:0), 
myristic (14:0), and palmitic acid (16:0) varied from 65% of saturated fatty acids for 
Zrenjanin in Serbia to 79% for Corfu and Crete (Table 6.4). Stearic acid content ranged 
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from 20% (Tanushimaru, Japan) to 32% (Zrenjanin, Serbia) of saturated fatty acids. The 
highest amount of saturated fatty acids of more than 20 carbon atoms was 2.5 g/day in 
Zutphen (Table 6.4). 
Monounsaturated fatty acids 
The range of mono-unsaturated fatty acids varied from 9.8 g/day in Tanushimaru, Japan, 
to 84 g/day on the Greek isle of Crete. The levels of monounsaturated fat in the food 
composites of Greece exceeded 20% of energy. 
Sixty to ninety percent of monounsaturated fat (Table 6.5) in the food composites 
occurred as oleic acid [cis C18:l,(«-9)]. The absolute amount varied from 8.0 g/day in 
Tanushimaru, Japan, cohort to 82 g/day in Crete. The second major monounsaturated fatty 
acid was palmitoleic acid [cis C16:l,(n-7)] with a highest consumption of about 4 g/day in 
Slavonia, Croatia. The maximum intake of both erucic [C22:l,(n-9)] and cetoleic acid 
[C22:l,(/i-ll)] was 2.9 g/day in Zutphen (Table 6.5). 
Total intake of very long chain fatty acids (saturated and unsaturated fatty acids with 
more than 20 carbon atoms) was about 14 g/day in Zutphen, and 2-5 g/day in the other 
cohorts (Tables 6.4, 6.5, and 6.6). 
Table 6.5 cis-Monounsaturated fatty acids in food composites from 16 cohorts of middle-aged men in seven 
countries, representing the average food intake in the 1960s, sampled in 1987 
Cohort 
US railroad, USA 
East-Finland 
West-Finland 
Zutphen, Netherlands 
Crevalcore, Italy 
Montegiorgio, Italy 
Rome railroad, Italy 
Corfu, Greece 
Crete, Greece 
Dalmatia, Croatian 
Slavonia, Croatian 
Belgrade, Serbia 
Velika-Krsna, Serbia 
Zrenjanin, Serbia 
Tanushimaru, Japan 
Ushibuka, Japan 
C14:l 
0.8 
1.3 
1.1 
0.6 
0.4 
0.2 
0.4 
0.1 
0.2 
0.3 
0.4 
0.6 
0.6 
0.3 
0.1 
0.2 
C16.1 
total 
3.0 
3.4 
2.8 
4.3 
2.7 
1.7 
1.6 
1.4 
1.3 
2.8 
5.3 
3.0 
2.6 
3.8 
0.8 
1.6 
(n-l)cis 
3.0 
3.0 
2.5 
1.7 
2.3 
1.4 
1.4 
1.2 
1.1 
1.9 
4.1 
2.8 
2.2 
3.0 
0.6 
1.3 
C17:l 
{n-l)cis 
0.4 
0.0 
0.3 
0.3 
0.0 
0.0 
0.2 
0.1 
0.2 
0.2 
0.0 
0.4 
0.2 
0.4 
0.0 
0.0 
total 
C18:l" 
(n-9)cis 
grams per day 
44 
49 
44 
37 
68 
47 
51 
61 
82 
73 
73 
49 
38 
59 
8.0 
15 
37 
42 
38 
29 
62 
42 
47 
56 
77 
67 
64 
43 
33 
52 
6.9 
13 
(n-l)cis 
2.6 
2.4 
2.4 
2.2 
4.6 
3.3 
2.8 
4.9 
4.7 
4.6 
7.0 
4.0 
2.8 
5.5 
0.9 
1.8 
C20:l 
0.4 
0.6 
0.7 
4.3 
1.0 
0.9 
0.8 
0.3 
0.4 
1.3 
2.0 
1.1 
0.7 
1.4 
0.0 
0.0 
C22:l 
0.1 
0.2 
0.3 
2.9 
0.3 
0.4 
0.3 
0.1 
0.1 
0.2 
0.3 
0.1 
0.3 
0.3 
0.8 
0.3 
C24:l 
0.0 
0.1 
0.0 
0.2 
0.0 
0.0 
0.0 
0.0 
0.0 
0.1 
0.1 
0.0 
0.0 
0.0 
0.2 
0.1 
' No C18:l(n-12)cir 
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Trans fatty acids 
The amount of trans fatty acids with 16 and 18 carbon atoms as determined by gas 
chromatography in Wageningen varied from 0.2 grams or 0.1 % of energy in Corfu, Greece 
to 8.6 grams or 2.8 % of energy in Zutphen, the Netherlands (Table 6.6). The highest 
levels, absolute as well as relative to energy intake, were found in the food composites of 
the Dutch, U.S., and Finnish cohorts, and the lowest amounts in those of Greece, Italy, and 
Japan. The main contribution to trans fatty acids was formed by trans isomers of C18:l 
(Figure 6.1). The food composite of Zutphen contained the highest amount of trans isomers 
of palmitoleic acid (16:1), while trans-l6:l was not present in the food composites of Italy, 
Greece, Croatia, and Zrenjanin, Serbia. The values measured in Finland by gas 
chromatography were on average 0.4 ± 0.9 g/day lower than in Wageningen. The value for 
Zutphen, Netherlands was 3.5 g/day higher while differences for other cohorts were less 
than 1 g/day. The total amount of trans fatty acids as assessed by infrared spectrometry was 
in general higher than the amounts of 16:1, 18:1 and 18:2 trans fatty acids assessed by gas 
chromatography (Figure 6.2). We found a large difference between the methods for the 
Zutphen cohort. 
Table 6.6 C16 and C18 trans fatty acids, as determined by gas chromatography, and total trans fatty acids as 
determined by infrared spectrometry in food composites from 16 cohorts of middle-aged men in seven countries, 
representing the average food intake in the 1960s, sampled in 1987 
Cohort C16:l C18:l(n-9) C18:l C18:2 C18:2 C18:2 Sum of Total trans 
(n-l)trans to (n-7)trans transjirans transfiis cisfrans trans fatty acids 
C18:(n-12) C16:1,C18:1 (infrared) 
trans C18:2 
US railroad, USA 
East-Finland 
West-Finland 
Zutphen, Netherlands 
Crevalcore, Italy 
Montegiorgio, Italy 
Rome railroad, Italy 
Corfu, Greece 
Crete, Greece 
Dalmatia, Croatian 
Slavonia, Croatian 
Belgrade, Serbia 
Velika-Krsna, Serbia 
Zrenjanin, Serbia 
Tanushimam, Japan 
Ushibuka, Japan 
0.3 
0.8 
0.6 
2.6 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.3 
0.1 
0.0 
0.1 
0.0 
3.9 
4.9 
3.6 
2.4 
1.1 
0.1 
0.7 
0.2 
0.4 
1.1 
1.2 
0.0 
2.2 
1.3 
0.0 
0.0 
0.0 
0.0 
0.0 
3.1 
0.0 
0.3 
0.0 
0.0 
0.0 
0.0 
0.0 
2.0 
0.0 
0.0 
0.1 
0.3 
grams/day 
0.3 
0.6 
0.2 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.2 
0.4 
0.0 
0.3 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.4 
0.4 
0.1 
0.3 
0.0 
0.1 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
5.0 
7.1 
4.5 
8.6 
1.1 
0.6 
0.7 
0.2 
0.4 
1.1 
1.2 
2.3 
2.3 
1.3 
0.2 
0.3 
6.0 
9.0b 
7.6b 
26 
1.8 
1.1 
1.6 
0.3 
0.6 
2.3 
2.1 
3.0 
3.8b 
1.4 
0.4 
0.4 
* determined in the research laboratory of the RAISIO group, Raisio, Finland; value for Zutphen determined in 
the Wageningen laboratory b average value of determinations in Raisio, Finland and in Wageningen 
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% of energy 
Figure 6.1 The amount of C16:l, C18:l, and C18:2 trans fatty acids according to gas chromatography in 
food composites from 16 cohorts of middle-aged men in seven countries, representing the average food intake 
in the 1960s, sampled in 1987 
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Figure 6.2 Sum of C16:l, C18:l, and C18:2 trans fatty acids according to gas chromatography in 
Wageningen and Raisio, Finland, and total trans fatty acids including C20 and C22 isomers according to 
infrared spectrometry in Raisio, Finland, in food composites from 16 cohorts and according to infrared 
spectrometry in Wageningen from 4 cohorts of middle-aged men in seven countries, representing the average 
food intake in the 1960s, sampled in 1987 
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Polyunsaturated fatty acids 
The polyunsaturated fatty acid fraction (Table 6.7) consisted for 54% to 85% of linoleic acid 
[18:2,(n-6)]. The intake of linoleic acid was high in the Serbian cohorts of Zrenjanin and 
Belgrade and in the United States, and low in Finland. As for the other (n-6) polyunsaturates 
the amount of y-linolenic acid [18:3,(/i-6)] was at the most 0.29 grams, and arachidonic acid 
[C20:4,(n-6)] 0.5 g per day. The content of the major n-3 (co-3) polyunsaturated fatty acid, a-
linolenic acid, varied from 0.79 grams in the diet of Rome railroad workers to 2.5 grams per 
day in east Finland. The food composites of Japan, Dalmatia, east Finland, and Corfu 
contained the highest, and those of the United States, Rome, and Velika-Krsna the lowest 
levels of eicosapentaenoic [EPA; C20:5(n-3) and docosahexanoic acid [DHA; C22:6,(n-3); see 
Figure 6.3). The ratio of linoleic to a-linolenic acid ranged from 3.2 in east Finland to 15 in 
Velika-Krsna (Table 6.7). T he (n-3) fatty acids have critical roles in membrane structure and 
are precursors of eicosanoids in the body. A number of studies have shown that the 
consumption of foods containing EPA and DHA is associated with decreased risk of coronary 
heart disease 20. a-Linolenic acid is elongated in the body to EPA and DHA, and the efficiency 
of this conversion is estimated to be about 20% 21. Therefore, 1 g of dietary a-linolenic acid 
is not equivalent physiologically to 1 g of EPA or DHA but to much less. In order to allow 
comparison of the total intake of (n-3) fatty acids across cohorts independent of source we 
multiplied a-linolenic acid intake by 0.2 and combined these values with intakes of EPA and 
DHA (Figure 6.3). The total intake of (n-3) fatty acids calculated in this way was highest in 
Ushibuka, Dalmatia, Tanushimaru, and east Finland (Figure 6.3). 
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Figure 63 The amount of the major (n-3) fatty acids in food composites from 16 cohorts of middle-aged men 
in seven countries, representing the average food intake in the 1960s, sampled in 1987, including 20% of the 
intake of C18:3 (n-3), as a measure for C18:3(n-3) converted into longer (n-3) fatty acids in the body. Values 
for C18:3 were divided by 5 because only about one-fifith of dietary C18:3 is elongated to EPA of DHA 2' 
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Sterols 
The amount of cholesterol varied from 170 mg per day in Tanushimaru to 612 mg in Slavonia 
(Table 6.8). Intakes of plant sterols were lowest in the United States, and highest in Greece. 
The amounts of campesterol varied from 41 (Slavonia) to 63 mg per day (east Finland), of 
stigmasterol from 9 (Finland and Rome) to 30 mg per day (Tanushimaru), and of sitosterol 
from 113 (U.S. railroad) to 281 mg per day (Corfu). 
Table 6.8 Cholesterol and plant sterols in food composites from 16 cohorts of middle-aged men in seven 
countries, representing the average food intake in the 1960s, sampled in 1987 
Cohort 
US railroad, USA 
East-Finland 
West-Finland 
Zutphen, Netherlands 
Crevalcore, Italy 
Montegiorgio, Italy 
Rome railroad, Italy 
Corfu, Greece 
Crete, Greece 
Dalamatia, Croatian 
Slavonia, Croatian 
Belgrade, Serbia 
Velika-Krsna, Serbia 
Zrenjanin, Serbia 
Tanushimaru, Japan 
Ushibuka, Japan 
Cholesterol 
582 
537 
492 
476 
585 
356 
409 
141 
211 
388 
612 
396 
359 
311 
170 
403 
Campesterol 
39 
63 
60 
60 
36 
36 
33 
60 
57 
44 
41 
59 
62 
54 
44 
60 
Stigmasterol 
mg per day 
19 
9 
9 
18 
12 
16 
9 
17 
16 
12 
24 
14 
12 
15 
30 
24 
Sitosterol 
113 
159 
149 
146 
172 
166 
136 
281 
252 
215 
151 
181 
181 
172 
134 
137 
Sum of 
phytosterols 
170 
232 
218 
224 
220 
218 
179 
358 
325 
272 
215 
254 
255 
242 
208 
221 
Sum of unknown 
compounds" 
33 
122 
96 
80 
93 
108 
91 
279 
261 
131 
89 
68 
73 
85 
71 
80 
' refers to all peaks in the non-saponifiable lipid extract that eluted after the cholesterol peak on gas chromatography 
Sources of visible fats 
The visible fats as reported in the food records (Table 6.9) contributed from 9.7 to 72% of the 
total amount of fat. The main source of visible fats in the U.S. and Finnish samples in the 
1960s was butter. In the Dutch sample Zutphen, margarine was more important than butter. 
Lard consumption was highest in the villages from Italy and the former Yugoslavia. The only 
visible fat eaten in the Greek cohorts was olive oil which was also an important fat source in 
Montegiorgio, Rome, and Dalmatia. In Belgrade the major visible fat was sunflower oil. The 
Japanese used small amounts of rapeseed (Tanushimaru) or peanut oil (Ushibuka). 
Comparison with food composition tables 
The largest difference between the calculated and chemically determined amount of total fat 
was 9% of energy or 40 g per day for Crevalcore (Table 6.10). For the other cohorts the 
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Table 6.9 Type and amount of visible fats reported in food records in the 1960s by middle-aged men 
living in 16 cohorts in seven countries 
Cohort 
US railroad, USA 
East-Finland 
West-Finland 
Zutphen, Netherlands 
Crevalcore, Italy 
Montegiorgio, Italy 
Rome railroad, Italy 
Corfu, Greece 
Crete, Greece 
Dalmatia, Croatia 
Slavonia, Croatia 
Belgrade, Serbia 
Velika-Krsna, Serbia 
Zrenjanin, Serbia 
Tanushimaru, Japan 
Ushibuka, Japan 
Butter 
26 
89 
66 
21 
13 
3.6 
18 
Margarine 
3.9 
7.7 
6.8 
56 
6.5 
Lard 
glday 
32 
40 
1.8 
16 
62 
9.0 
24 
44 
Olive oil 
4.3 
40 
43 
75 
95 
72 
7.8 
Sunflower 
oil 
2.9 
28 
5.2 
12 
Other 
3.1' 
1.9h 
3.2' 
7.3b 
' soy oil 
h
 peanut oil 
' rapeseed oil 
difference varied from 0.1 to 3% of energy. The largest difference for saturated fat was 3.5%, 
for monounsaturated fatty acids 4%, and for polyunsaturated fat 1.6% of energy. The 
difference between calculated and chemically determined cholesterol was at the most 6 mg/MJ 
or 21 mg/day (Table 6.10). 
Discussion 
We found large differences in the amounts of total fat, fatty acids, and sterols between the 
seven countries, and between cohorts in the same country. The difference between the highest 
and the lowest value for trans fatty acids in food composites was 8 g per day (2.8% of energy) 
for those trans fatty acids detectable by gas chromatography, and 25 g per day (8.3% of 
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energy) for the total amount of trans fatty acids as detected by infrared spectrometry. The sum 
of the long-chain n-3 fatty acids, EPA and DHA, between the highest and the lowest value, 
differed by almost 2 g per day. Amounts of fish providing these or smaller amounts of EPA 
and DHA are associated with marked differences in coronary heart disease incidence. Most 
differences can be explained by the differences in food intake, for example, higher intakes of 
hydrogenated fats and milk resulted in higher trans fatty acids levels, and higher fish 
consumption in a higher EPA plus DHA content of the food composites. 
Two important questions are: (i) whether chemical analysis of food composites based 
on food records and composed 30 years after food recording provided valid data, and (ii) to 
what extent the results of samples may be extrapolated to the full cohorts and to their 
respective countries. 
Table 6.10 Comparison of the energy and nutrient content of food composites representing the average food 
intake in the 1960s, sampled in 1987 of the U.S., Finnish, Dutch, and Italian samples, according to calculation 
from food tables (Calc.) and to chemical analysis (Anal.) 
Cohort 
US railroad 
Finland East 
Finland West 
Zutphen 
Crevalcore 
Montegiorgio 
Rome railroad 
Energy 
Calc. 
10.2 
14.6 
14.3 
12.0 
14.6 
12.6 
12.9 
MJ 
Anal. 
9.6 
14.7 
14.4 
11.3 
15.2 
12.1 
11.0 
Fat 
Calc. 
49 
39 
36 
46 
29 
28 
32 
Anal. 
50 
42 
36 
45 
38 
31 
32 
Saturated 
fatty 
Calc. 
20 
20 
17 
18 
9.7 
8.6 
10 
acids 
%of 
Anal. 
21 
22 
19 
20 
13 
9.6 
11 
Mono 
unsaturated 
fatty 
energy 
Calc. 
18 
11 
10 
17 
14 
13 
17 
acids 
Anal. 
19 
14 
13 
16 
18 
15 
21 
Poly 
unsaturated 
fatty 
Calc. 
6.5 
2.1 
2.3 
5.1 
3.6 
5.0 
3.6 
acids 
Anal. 
8.1 
3.8 
3.5 
6.6 
5.0 
4.5 
3.9 
Cholesterol 
MglMJ 
Calc. 
55 
34 
34 
36 
33 
25 
36 
Anal. 
61 
36 
34 
42 
38 
29 
37 
Food records 
We selected the amounts and types of foods for composing the food composites on the basis 
of food records from the 1960s. Weighed food records give an average underestimation of 
energy intake of some 10% 22, but they still remain the most accurate method of dietary 
assessment 23. Body mass index, age, and gender appear to be the major factors associated with 
underreporting 24"26, although some studies did not find an effect of obesity 27'28. However, 
obese men in the Zutphen cohort reported a lower energy and fat intake than their lean 
counterparts M. Therefore, the energy and fat content of the food composites of Rome, 
Belgrade, Crevalcore and US railroad, where the men with the highest relative body weights 
lived (body mass index > 25), might have been underestimated more than in the other cohorts. 
Nevertheless, the proportional contribution of fat, fatty acids, and sterols might be still 
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reasonably correct, so that the data of these cohorts are still valuable. Gender and age 
range did not differ between the cohorts. 
The reconstructed data of Greece appear to be useful, as they result in a total fat 
composition for Crete and Corfu that agrees with that reported earlier 30. Although we derived 
the food composite of the USA from only 1-day records, it can still be considered 
representative for the food intake of the cohort, because food records of 30 men were used. 
It is uncertain if the eight Ushibuka men were representative for the men in their cohort, but 
as the total fat level of the food composite agrees with other data of Japanese dietary surveys 
8,3
°, they probably were. 
We do not expect that seasonal variation had a large effect on the results of our study. 
Seven day surveys covered seasons of the year, and the intake of energy-yielding nutrients was 
relatively constant throughout the year 5. 
Food sampling 
Most foods to be collected for the food composites were available. We acquired them within 
five months and sampled the foods for all cohorts in the same way. All food composites were 
analyzed in one laboratory. Although the relative position of the cohorts in the distribution of 
different foods between 1961-65 and 1975-77 was maintained 6, foods probably have changed 
in their total fat, fatty acid and sterol composition between the 1960s and the 1980s 8. Meat 
and dairy products with the same total fat content as recorded by the men were largely still 
available. We only selected margarines of the stick form made from the same hydrogenated 
oils as in the 1960s. The main edible fat was margarine only in Zutphen, and as we 
periodically monitor the fat composition of Dutch margarines 31, it was possible to choose a 
margarine with a highly similar fatty acid composition in 1987. 
In the 1960s, chemical analysis for determination of a limited number of nutrients of 
equivalent composites provided the amount of saturated, monounsaturated and polyunsaturated 
fatty acids for 13 of the 16 cohorts 4'5. The correlation coefficients between these 
determinations and those found in our study for the same cohorts were 0.92 (p<0.001) for 
saturated fatty acids, 0.95 (p<0.0001) for monounsaturated fatty acids, and 0.65 (p<0.02) for 
polyunsaturated fatty acids. Therefore, we apparently succeeded in selecting the right foods, 
and composing representative food composites. 
Chemical analysis 
We were not able to assess butyric (C4:0) and caproic (C6:0) acids, due to workup of the 
samples and the method used for gas chromatography. Butyric and caproic acid contribute 
about 5% of total fatty acids in dairy products 32. We calculated that as a result we could have 
missed at most about 3 g of fat per day in the cohorts with a high consumption of dairy 
products. 
We considered the methods used well validated for food composites with more than 5% 
of fatty acid methyl esters. We used internal quality control samples, and within and between 
variations of determinations of these samples were respectively 1.4 and 1.7% for total fat 
(mean 18 g, n = 20), 1.4 and 2.0% for C16:0 (mean 34 g, n = 64), 2.9 and 3.6% for C18:0 
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(mean 5.2 g, n = 64), and 1.8 and 2.4% for C18:2 (mean 15 g, n = 64). 
Comparisons between trans fatty acids levels between assessment by gas 
chromatography and Fourier transform infrared spectrometry, performed in the two laboratories 
showed good agreement, except for the Zutphen cohort which contains C20 en C22 
polyunsaturated fatty acids in the trans configuration. 
The recovery test for detection of (n-3) fatty acids showed that very small amounts of 
C20:5(n-3) and C22:6(n-3) could be determined accurately in the food composites. From all 
this it appears that our data are valid estimates of the fatty acid and sterol composition of the 
diets. 
Calculation by use of food composition tables 
The results of calculation by use of food composition tables agreed well with those of 
chemical analyses, except for the high fat content of the Crevalcore composite. This difference 
may be caused by a decrease of fat content of foods from the sixties to the eighties, although 
we did not find differences between calculated and analyzed fat content of this magnitude for 
Montegiorgio and Rome, for which we used the same food composition tables as for 
Crevalcore 1618. The total fat content assessed in the 1960s corresponds with the lower 
calculated level. This could point to selections of food with a fat content too low for this 
cohort. The calculations indicate that the difference in fat content was distributed evenly over 
the different fatty acids. 
Fatty acid composition 
Medium-chain fatty acids and stearic acid do not raise plasma LDL 33"37. We found small 
differences in medium- chain fatty acid intake between cohorts, but stearic acid was 10 times 
higher in Finland and Slavonia than in Japan (Table 6.4). Palmitic (C16:0), myristic (C14:0), 
and lauric acid (C12:0) clearly raise LDL cholesterol, and therefore are considered atherogenic 
i,36,38 pmiancj na(j m e highest intakes of all three of these fatty acids, due to a high intake of 
butter and milk, and Tanushimaru, Japan had the lowest. 
Oleic acid in the diet shows beneficial effects on the lipoprotein risk profile for 
coronary heart disease 37"39. Cohorts in Greece, Italy, and the former Yugoslavia, with a high 
consumption of olive oil, showed the highest intake of oleic acid. Long-chain monoenoic fatty 
acids with 20 and 22 carbon atoms occur in margarines containing partially hydrogenated 
marine oils. That was confirmed for the Zutphen sample, in which these fatty acids contributed 
1% of energy. Erucic acid (C22:l) may cause cardiac lipidosis in rats 32. The effects in humans 
are not clear, but toxicity is likely to be much less in a mixed diet 32. A regulation in the 
European Community limits the erucic acid in foods to 5% of fat content. The highest amount 
of this fatty acid in our study, 0.9% of energy or 2% of fat content in the sample of Zutphen, 
was below this level. The erucic acid in Tanushimaru (Table 6.5) probably came from 
rapeseed oil. 
Trans unsaturated isomers of 18:1 and 18:2 fatty acids are formed during partial 
hydrogenation of oils rich in linoleic and oleic acid. There is increasing evidence that these 
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trans fatty acids raise LDL, and reduce high-density lipoprotein cholesterol levels 40"42. Sources 
for trans fatty acids are dairy products, meat, and margarines, cooking fats, and shortenings 
made with partially hydrogenated oils 2J2'43. The data for C16 and C18 trans fatty acids 
assessed by gas chromatography agreed well between the Finnish and the Wageningen 
laboratory (cf. Methods). We found higher values by using infrared spectrometry. The gas 
chromatography values could be an underestimation due to a partial overlap of C18:l cis and 
C18:l trans positional isomers, and because they do not include trans fatty acids of 20 carbon 
atoms and more. The high values for total trans fatty acids for Zutphen (Figure 6.2) can be 
explained by a high consumption of margarines with hydrogenated fish oils. These oils contain 
large amounts of trans isomers with 20 or 22 C atoms which can be detected by infrared 
spectrometry but not by gas chromatography. The high amount of fatty acids with more than 
20 carbon atoms in the Zutphen sample (14 g/day) confirmed the presence of hardened fish 
oils. Also, the high C16:l (n-7) trans value for Zutphen probably originated from 
hydrogenated fish oils in margarines. 
Aitchison u determined the mean daily intake of trans fatty acids by duplicate portion 
analysis for 11 and van den Reek 45 for 8 American women. Total trans fatty acids relative 
to energy agreed well with our value for the U.S. cohort: Aitchison found 1.8 g/1000 kcal, van 
Reek 2.1 g/1000 kcal, and we found 2.2 g/1000 kcal. The average daily intake of trans fatty 
acid for the USA was estimated as 8.1 g/day (about 3.9 g/1000 kcal) by Hunter46, and as 13 
g/day (about 6.3 g/1000 kcal) by Enig 47, as opposed to 5.0 g/day (2.2/1000 kcal) for our 
sample. The estimates of Hunter46 and Enig et al. were based on disappearance and market 
share data, respectively, which may overestimate actual intake. Also, trans fatty acid intake 
could have risen between the 1960s and the 1980s as margarines replaced butter in the diet; 
margarines free from trans were available at that time in Europe 48, but not in the United 
States. 
The trans fatty acid level determined in a representative Finnish diet in 1987 49 was 1.7 
g/day or 0.7 g/1000 kcal, while the Finnish value in our composites was 5.8 g/d or 1.7 g/1000 
kcal. The difference could be partly explained by a decreased fat intake since the 1960s. 
Probably, it is even smaller in Finland nowadays, because the intake of fat has declined 
further, and all margarines and most vegetable fat blends have been reformulated and are very 
low in trans fatty acid content (Dr. Ingmar Wester, Raisio personal communication). 
The amounts of trans fatty acids in the duplicate samples of a Dutch market basket 
study 50'51 was estimated to be 10.0 g/day or 3.2/1000 kcal, which agreed well with our value 
for the Dutch cohort Zutphen (8.6 g/day or 3.1 g/1000 kcal). Although both values may not 
be considered as representative for the Dutch population, they indicate that the intake of trans 
fatty acids in the Netherlands remained the same between the 1960s and the 1980s. 
The (n-6) and (n-3)-fatty acids are essential for the formation of membranes, and are 
precursors of eicosanoids which have a variety of functions 52H. The presence of (n-3) 
polyunsaturated fatty acids in the diet may reduce the risk of coronary heart disease 54. Fish 
oils are a rich source of (rc-3) fatty acids and have a high content of fatty acids with 20 or 
more carbon atoms. This was reflected by high contents of these fatty acids in the food 
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composites of east Finland, the isle of Corfu in Greece, Dalmatia on the Yugoslavian coast, 
and Japan, which had a high fish consumption. We found differences in the intake of the (n-3) 
polyunsaturated fatty acids, EPA and DHA, of almost 2 g per day. Some studies suggest that 
the ratio between (n-6) and (n-3) polyunsaturated fatty acids is important in the prevention of 
coronary heart disease 8'55. Experts recommend a ratio of linoleic to a-linolenic acid in the diet 
between 5:1 and 10:1 8. Only 6 of the 16 cohorts met this advice (Table 6.5); in the other 10 
cohorts the ratio was lower for 1 and higher for 9. A problem with the use of this ratio is that 
a-linolenic acid is not equivalent to longer chain (n-3) fatty acids because only some 10-20% 
is elongated. Therefore indexes or recommendations for (n-3) fatty acid should probably take 
into account the lower "biological value" of a-linolenic acid relative to EPA and DHA; we 
have attempted to correct intake figures in this way in Figure 6.3. 
The values for (n-3) and (n-6) polyunsaturated fatty acids in our study agreed rather 
well with those from earlier Finnish and Dutch studies 49,5°, and corresponded with fish 
consumption levels of the cohorts 6. 
Sterols 
Dietary cholesterol is present in animal foods and is seen by some as an independent risk 
factor for coronary heart disease (Stamler and Shekelle 1988). A cholesterol intake of less than 
300 mg per day is recommended 8. We found high cholesterol intakes (> 475 mg/day) in the 
U.S. railroad workers, east Finland, west Finland, Zutphen, Crevalcore, and Slavonia; these 
were generally due to a high intake of milk fat, eggs and meat. Sterols in plants, phytosterols, 
are poorly absorbed, and interfere with the absorption of cholesterol. Large intakes may lower 
LDL cholesterol levels 8. A high consumption of vegetable oils and a relative high intake of 
bread contributed to the high content of plant sterols in the Greek duplicates 56. Our results 
confirm previous values for plant sterol intakes of 160-360 mg per day, amounts which 
probably have little effect on plasma cholesterol 57. 
Visible fats 
Visible fats were the most important fat source in the diets. Margarine and butter were major 
contributors to the high saturated and trans fatty acid content of the Finnish, Dutch and 
American diets, and olive oil to the mono-unsaturated fatty acid content of the Greek, Italian, 
and former Yugoslavian diet. A high consumption of lard (e.g. Slavonia) led to high intakes 
of total and saturated fat, but not of trans fatty acids. For the Japanese cohorts visible fats 
were not an important contribution to fat intake. The amounts and types of visible fats 
correspond with the fatty acid and sterol composition of the diets, which confirms the accuracy 
of our data. 
Conclusion 
We conclude that the assessment of fatty acids and sterols in the diets by chemical analysis 
of equivalent food composite portions is an adequate tool for estimating the average intake of 
subsamples of populations. However, the results of one or two cohorts do not necessarily 
reflect the average intake of a country. 
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We found large differences in the amount of total fat, fatty acids and sterols between 
cohorts, which reflected the variations in food consumption patterns. Chemical analysis of 
equivalent food composite portions allows assessment of more fatty acids and sterols than 
when using food tables, so that information on the intake of less known fatty acids and sterols 
can become available. 
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Abstract 
We assessed how accurately participants in dietary trials reported their free-living energy 
intake. We compared self-reported energy intake, calculated from 3-day food records, with 
actual intakes needed to maintain body weight during controlled trials lasting 6-9 weeks. 
In 269 free-living healthy male (n = 119) and female (n = 150) adults with mean body 
weights close to ideal values (x ± SD body mass index in kg/m2, 22.1 ± 2.4), energy intake 
reported in food records was 1.2 ± 1.6 MJ/d (277 ± 378 kcal/d) lower than actual energy 
requirements during the experiments. The relative bias was significantly smaller (P = 0.01) 
for men (-8.0 ± 13.4%) than for women (-12.2 ± 13.7%). Body mass index, daily energy 
intake, and age were not significantly related to the extent of underestimation. We conclude 
that food records systematically underestimate energy needs in young, non-obese well-
educated adults. 
Food records and actual energy intake 91 
Introduction 
Food-intake data are used in epidemiological research and for assessing nutrient 
requirements. There are several methods to estimate dietary intake. However, the validity 
of most methods is uncertain. In general, recall and record methods result in much lower 
energy intakes than do doubly labeled water estimates of energy expenditure or supervised 
feeding to maintain body weight 12. 
Some characteristics of subjects who provide good records or of severe 
underreporters have been described. In literate and highly motivated subjects, self-report by 
dietary records yielded good agreement between mean energy intake and mean energy 
expenditure '. It appears that self-reports are not representative of energy requirements in 
obese subjects 3"6. It has also been suggested that the degree of underreporting increases 
with the level of energy intake 2J. An explanation for this could be that individuals tend to 
report intakes that are closer to perceived norms than to actual intake 7. 
The aim of our study was to determine whether young, lean, highly educated adults 
would provide valid estimations of their energy intake. Therefore, we compared self-
reported energy intakes from 3-day dietary records with the actual amount of energy 
required to maintain stable body weights in dietary experiments. In these studies the feeding 
of diets with known energy contents was supervised and this provided us an almost "golden 
standard" for determining energy intake. 
Subjects and methods 
The experiments and diets 
Actual energy needs were defined as the amount needed to maintain weight during 
controlled trials. Data were obtained from six dietary trials each with a duration of 6-9 
weeks, which were conducted between 1986 and 1993; key aspects are summarized in 
Table 7.1. We performed experiments 2 and 3 in October and November, and the others 
between January and April. Approval for all studies was obtained from the Ethics 
Committee of the Department of Human Nutrition and Human Epidemiology. 
The experimental diets varied in total fat content and fatty acid composition. 
Vitamins and mineral contents of the diets met the recommended dietary allowances of the 
Dutch Food and Nutrition Council 8. The diets were made available at 30 energy levels 
ranging from 5.5 MJ to 20 MJ (1315 to 4782 kcal) per day, in increments of 0.5 MJ 
(120 kcal). We supplied each individual with a diet that met his or her energy requirement, 
as judged by stable body weight during the trial. The diets consisted of conventional solid 
foods. On weekdays volunteers consumed their hot meals at the Department. All other food 
was supplied daily as a package and consumed at home. We provided about 90 % of total 
daily energy. Each day participants selected the remaining 5-13 % of energy from a list of 
foodstuffs low in fat and cholesterol. These free-choice items provided an amount of energy 
fixed for each energy level. We allowed subjects unrestricted consumption of coffee and 
tea without milk and sugar, and of water, herbs and spices, lemon juice, vinegar, and non-
energy soft drinks. The subjects kept a diary in which they recorded their daily choice of 
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free-choice items and any deviation from the guidelines. 
During the experiments we contacted subjects on every weekday and advised them 
about the diets and the protocol if necessary. We urged subjects not to change their 
smoking habits and physical activity. They were asked to record any relevant change in 
their diaries. Other details have been described 9"14. 
Table 7.1 Overview of the dietary trials 
Study and 
year 
1. 19869 
2. 198710 
3. 198811 
4. 199012 
5. 199213 
6. 199314 
Duration 
wk 
8 
7.5 
9 
9 
9 
6 
Fat content 
of diets 
% of energy 
22 or 39 
37 
39 
41 
39 
40 
Number of 
Total 
(n=351) 
57 
60 
59 
56 
59 
60 
subjects 
Included in 
analysis 
(n=269) 
45 
48 
48 
48 
45 
35 
Subjects 
We recruited volunteers via local newspapers, via posters, and by approaching former 
participants. For the six trials combined a total of 441 persons were screened. Because 48 
of them participated more than once these subjects generated 503 data points. The subjects 
lived in or around Wageningen, a small college-town in the center of the Netherlands. 
We supplied ample oral and written information about the aim of the study and the 
burden involved in participating. We measured blood pressure, urinary glucose and protein, 
obtained a written medical history and asked subjects to record their food intake for 3 days. 
Eight (1.6%) subjects were excluded because of a history of atherosclerotic disease, 
hypertension, anaemia or other medical conditions as judged by an independent physician, 
or because their alcohol intake exceeded 10% of daily energy. We excluded 25 (5.0%) 
applicants because they disliked foods that were essential parts of the study diets (eg, dairy 
products or olive oil). Another 25 (5.0%) withdrew for personal reasons before the trials 
started. Because men and older persons were underrepresented we admitted most of them, 
as well as their partners. Because only 60 subjects could be admitted to each trial, we 
excluded another 94 (18.7%) eligible persons by random lottery. A total of 351 (69.8%) 
subjects were enrolled in the six experiments. They gave their written informed consent for 
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participation. 
For the present analysis 9 subjects (2.6% of the participants) were left out because 
their food records were missing or because they withdrew before the end of the trial. We 
omitted results of another 11 (3.1 %) subjects because they had gained or lost more than 
2.0 kg body weight between day 14 and the last week of the study. Forty-eight subjects 
participated in more than one trial. We used the data from their first trial and dropped the 
62 observations (17.7%) from their subsequent trials, because of possible bias from multiple 
participation. This left 269 (76.6%) observations. Characteristics of the subjects are 
presented in Table 7.2. 
Table 12 Subject characteristics 
Age (y) 
Age > 30 y (n) 
Height (cm) 
Weight at 
start of trial 
BMI2 
BMI > 25.0 (n) 
All 
(n = 269) 
25.7 ± 9.61 
43 
177.1 ± 9.4 
69.5 ± 9.6 
22.1 ± 2.4 
34 
Men 
(n = 119) 
25.4 ± 9.3 
17 
184.5 ± 6.6 
75.4 ± 8.2 
22.2 ± 2.5 
14 
Women 
(n = 150) 
25.9 ± 9.8 
26 
171.1 ± 6.6 
64.8 ± 7.8 
22.1 ± 2.4 
20 
' x ± SD 
2
 In kg/m2 
The subjects were highly educated: in study 5 two subjects had completed primary school 
only, all others had completed secondary school, most of whom were attending college. In 
experiments 5 and 6, 55-60 % of the subjects were students, and 30-35% were employed; 
the remaining subjects were housewives or unemployed. It is likely that the characteristics 
of subjects in experiments 1-4 were similar. Fifty-eight (21.6%) participants were lacto-
ovovegetarians or disliked some kinds of meat. These subjects received diets without meat, 
which we compensated for by providing cheese, marmalade, oil, and eggs so as to achieve 
the same energy and macronutrient composition as the corresponding test diet with meat. 
Forty-seven women (31% of all women) used oral contraceptives. The participants received 
no financial reward except for the free food. 
Food records 
Two to three months before each trial the volunteers recorded their food intakes for two 
weekdays and one weekend day, using scales weighing the nearest gram (study 1-3) or 
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estimating quantities in household measures (study 4-6). Recording days were chosen at 
random and only changed if a serious deviation from habitual food intake could be expected 
(eg, major festivities). This occurred for only one or two subjects per experiment. 
Dieticians employed for the assessment of dietary intake followed a course in food-
consumption techniques developed at our Department (Blauw et al, unpublished 
observations) or were thoroughly instructed. During the first visit of the subject to our 
Department the dietician provided diaries for recording food intake plus oral and written 
instructions. The importance of keeping accurate records was explained; the subjects were 
told that the results would be used for determining their energy intake level during the 
experiment and that they were not allowed to gain or lose weight. Additional instruction 
was given about the use of scales to participants of studies 1-3 and about recording the 
amounts of foods in household measures to the participants of studies 4-6. 
At the second visit of the subject to our Department the dietician checked whether 
the food records had been filled out properly, obtained additional information about poorly 
defined dishes and recipes and unclear items or amounts, and displayed examples of cups, 
glasses and spoons to improve the estimation of household measures. The volunteers also 
spread a slice of bread with their habitual amount of margarine and the portion size for 
coding food records was corrected if necessary. 
The dieticians estimated other portion sizes by using a table of common household 
units. One dietician (JdV) checked and supervised the subsequent coding of the records and 
data-entry procedures. The energy content was calculated using the Netherlands Nutrient 
Data Base 1985 (14). Additional data on food composition were obtained by chemical 
analysis or from the food industry. 
Energy intake during the experiments 
At the start of the trial each subject was assigned a 10% higher energy intake than the value 
from the food records at the start of the trial because an underestimation was expected from 
the literature and from previous experience. Body weights were measured twice weekly 
before lunch with subjects wearing no shoes or heavy clothing such as jackets and sweaters. 
If body weight tended to change by > 0.2 kg, we adjusted the energy intake by raising or 
lowering it in steps of 0.5 MJ/day so as to maintain a stable body weight, ie, < 2.0 kg 
between day 14 and the end of the experiment. 
We calculated the energy content of the experimental diets using the same data base 
as for the food records (14) and used this for the comparisons with self-reported energy-
intake. In addition, each day we collected duplicate portions of each experimental diet for 
an imaginary participant with an energy intake of 10 MJ/day (2391 kcal, studies 1-3) or 
11 MJ/day (2630 kcal, studies 4-6). Duplicates were stored at -20° C, pooled, and 
chemically analyzed for protein 15, total fat 16, fatty acid composition 17, dietary fiber 18, and 
cholesterol 19. Available carbohydrate was calculated by the difference between total energy 
content and the amount of energy derived from protein and fat. The energy content 
calculated from these analyses plus the determined contribution of the energy intake from 
the consumed free-choice items yielded a check of the energy content of the diets as 
Food records and actual energy intake 95 
calculated from the food table. 
The mean decrease in body weight of all subjects was 0.32 ± 0.65 kg between days 
1 and 7, 0.15 ± 0.53 kg between days 8 and 14, and 0.05 ± 0.91 kg between day 14 and 
the last week of the experiments. Seventy-five (28%) subjects lost or gained > 1.0 kg but 
< 2.0 kg between day 14 and the end of the experiment. We defined actual individual 
energy intakes as the mean energy level between day 14 and the end of the trial. 
Dietary adherence was confirmed by the individual changes in the fatty acid 
composition of serum cholesteryl esters or erythrocytes, which were consistent with the 
differences in the dietary fatty acid composition in experiments 2, 3, 4 and 5 10"13. 
Anonymous questionnaires on compliance were filled out in studies 5 and 6. Inspection of 
these questionnaires and the diaries did not reveal deviations from the protocol that might 
have affected the results. It was estimated that illegal foods supplied at most 0.02 MJ or 5 
kcal per day (study 5 and 6). 
Statistical analysis 
The null hypothesis was that the energy intake estimated from the 3 day food records before 
the study would not differ from the average energy need from day 14 until the end of the 
study. This was analyzed by a paired t-test with use of the Statistical Analysis System 20. 
Differences between subgroups were tested by unpaired t-tests 20. 
Results 
Self-reported energy intakes versus calculated energy needs 
Pretrial energy intake as reported in the 3-day records was on average 10.6 ± 3.0 MJ/day 
(2533 kcal/d ± 717). There was no difference between the three recording days; mean 
reported energy intake was 10.7 ± 3.4 on the first day, 10.6 ± 3.5 on the second day, and 
10.4 ± 3.6 MJ on the third day. Actual intakes between day 14 and the end of the trial -
when body weights were stable - averaged 11.7 ± 2.6 MJ/day (2796 ± 621 kcal/day). Mean 
self-reported energy intake was 10.4% lower than the energy need during the experiments 
(Table 7.3). The Pearson correlation coefficient between the recorded amount of energy and 
actual energy requirement was 0.85 for all subjects, 0.70 for the men, and 0.73 for the 
women (P<0.0001). 
The absolute differences were similar for men (-1.1 MJ/day; 95% CI -1.4 to 
-0.8 MJ/d) and women (-1.2 MJ/day; 95% CI -1.4 to -1.0 MJ/d), but when expressed as a 
percentage of energy intake during the experiments the food records underestimated energy 
needs more in women (- 12.2%; 95% CI, -14.4 to -10.0%) than in men (- 8.0%; 95% CI, 
-10.4 to -5.6%, P for difference between men and women = 0.01). The underestimation in 
the 43 subjects aged 31 - 67 years was 10.7% versus 8.5% for the younger adults (P = 
0.33). The 34 participants with a body mass index (BMI, in kg/m2) > 25 kg/m2 
underestimated their energy intake by -12.0% as compared with -10.1% for the 235 subjects 
with a body mass index s 25 (P = 0.53). Men with a body mass index of > 25 (n = 14) 
underestimated their energy intake by 15.0%, and men with lower BMIs (n = 105) by 7.1% 
(P = 0.06). In women the underestimation was 12.6 % for the higher BMI-group 
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Table 13 Preexperimental daily energy intake reported in 3-d records vs actual energy 
intake required to maintain weight during controlled trials in non-obese adults 
Reported intake 
(MJ) 
(kcal) 
Required intake 
(MJ) 
(kcal) 
Difference2 
(MJ) 
(kcal) 
Percent difference (%) 
All subjects 
(n=269) 
10.6 ± 3.01 
2533 
11.7 ± 2.6 
2796 
- 1.2 ± 1.58 
- 277 
- 10.4 ± 13.7 
Men 
(n=119) 
12.8 ± 2.6 
3070 
14.0 ± 1.9 
3338 
- 1.1 ± 1.84 
-268 
- 8.0 ± 13.4 
Women 
(n=150) 
8.8. ± 2.0 
2089 
9.9 ± 1.4 
2373 
- 1.2 ± 1.34 
- 283 
- 12.2 ± 13.7 
1
 x ± SD. 
2
 All differences are significantly different from zero, P < 0.05. 
(BMI > 25, n = 20) and 9.9% for the lower BMI-group (BMI <; 25.0, n = 130; 
P = 0.54).The degree of underestimation was not correlated with absolute energy intake in 
both sexes combined (r = 0.00, P = 0.92) or in men (r = 0.00, P = 0.93), and weakly 
correlated in women (r = 0.15, P = 0.07). We found no association between misestimation 
and the change in body weight between day 14 and the end of the trial (r=-0.06, p=0.33). 
The average underestimation was - 8.8 ± 14.9% in studies 1-3, when foodstuffs were 
weighed, and - 12.1 ± 12.0 in studies 4-6, when the amounts of food were estimated 
(P = 0.05). When all data of the 48 participants who participated twice or more were 
included (adding 62 observations, n=331) the underestimation was - 8.6% ± 13.3 for men 
and - 12.9% ± 14.1 for women versus - 8.0 % for men and - 12.2 % for women in the 
initial data set (n=269). 
The chemical analysis of duplicate portions showed that the energy content of the 
provided diets was on average 0.2 MJ or 48 kcal/d (range - 0.1 to 0.5 MJ) lower than we 
calculated using the food table. Duplicate portions collected for a lower (8.0 MJ or 
1913 kcal) and a higher (14.0 MJ or 3348 kcal) energy level in experiment 3 yielded 
similar results. 
Table 7.4 shows that the mean underestimations differed between experiments. The 
average underestimation of 10.8% in experiments 2 and 3, which took place in autumn, was 
not significantly different from the 10.1% in experiments 1, 4, 5, and 6, which were 
performed in the spring. 
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Table 7.4 Recorded minus actual energy intake per study1 
Study Percent difference 
1 (n=45) - 4.6 ± 7.1 
2 (n=48) - 14.3 ± 9.6 
3 (n=48) - 7.2 ± 21.8 
4 (n=48) - 13.0 ± 12.1 
5 (n=45) - 13.1 ± 11.4 
6 (n=35) - 9.4 ± 12.8 
x ± SD. Pre-experimental energy intake in studies 1-3 was recorded by weighed portions and in studies 4-6 
by estimated portions. Studies 2 and 3 were executed in autumn and studies 1, 4, 5, and 6 in spring. 
Discussion 
The subjects in our study undoubtedly underestimated their energy requirements when they 
recorded their food intake for 3 days. Although a self-reported energy intake of 10% less 
than actual energy intake seems small, the consequences for the interpretation of nutrition 
survey data are substantial. 
The precision of the method proved to be high, as indicated by the strong association 
between reported and actual energy intake. Note that this association might be slightly 
inflated because the dietary records were used to calculate the energy needs during the 
trials. However misestimation was not associated with the change in body weight, which 
suggests that energy need as determined during the trials was independent of the over- or 
underestimation of energy reported in the dietary records. Thus, inflation - if any - could 
not have been substantial. The degree of underestimation was weakly associated with BMI 
in men, but not with BMI in women, age, or absolute level of energy intake. However, the 
relative underestimations were higher for women than for men. 
It is conceivable that subjects intentionally underreported their food intake because 
they wanted to lose weight during the experiments. However, this is not likely because they 
knew that weight loss was not allowed during the trials and that their energy intake would 
be adjusted. Also, they were not obese. The participants were well-educated and the 
applicants with excess alcohol intakes were excluded. For these reasons the subjects in our 
study would be expected to provide accurate records \ 
The reported energy intakes of our subjects agreed with the results of the Dutch 
National Food Consumption Survey 21 for which a 2-day record was used. For women 
(n=1611) in the same age range, the reported energy intake was 9.0 MJ (2151 kcal) vs 8.7 
MJ (2080 kcal) in our study and for men (n=1608), aged 16 to 49 years, 12.3 MJ 
(3940 kcal) vs 12.8 MJ (3059 kcal) observed here. 
The differences between energy content of the diets as assessed by chemical analysis 
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and the calculated value would imply an average energy intake during the experiments of 
11.5 MJ/d instead of 11.7 MJ/d. The difference between analyzed and calculated values was 
probably due to a slight overestimation of the energy content of foods in the nutrient 
database. In that case a correction should also be applied to the database used for evaluating 
the food records, and the degree of underreporting would remain unchanged. If the 
difference between calculated and analyzed energy contents of the experimental diets was 
due to smaller amounts of food being provided than planned for them, the degree of 
underreporting would become 7.8% instead of 10.4%. However, this is less likely to have 
happened because all foods were weighed out on high-quality scales which were 
periodically recalibrated. The average weight loss between day 14 and the final week of the 
experiment was 50 g, or 1.2 g/day. This implies that as a group our subjects were very 
close to energy balance and that the subjects' actual energy requirements were even slightly 
higher than calculated here. 
The deviations from the protocol recorded in the diaries and filled out in the 
anonymous questionnaires would implicate that the subjects' energy intake was only 
0.02 MJ/d (5 kcal/d) higher than determined. If subjects did underreport their extra 
consumptions, then the discrepancy between reported and actual energy intake would 
increase and the conclusions of this study would be reinforced. Although 2 or 3 months 
elapsed between the recording of food intake and the start of the trial, there is no plausible 
reason, why subjects should have increased their energy expenditure. The degree of 
underreporting was the same for experiments performed in autumn, with food records 
obtained in July and August, as for experiments performed in January - April with food 
records obtained in November and December. Thus seasonal fluctuations in activity do not 
explain our findings. The differences in underestimation between experiments as shown in 
Table 7.4 could be due to the use of different recording methods, because dietary records 
by estimated portions provide in general less accurate estimations than by weighed amounts 
of foods. 
Comparison with other studies 
The mean energy needs of our subjects were approximately the same as those in a number 
of other studies 1|2. The men in our study consumed on average 14 MJ/day (3346 kcal) and 
the women 9.9 MJ (2379 kcal), whereas others ''2'22'23 found on average 13.5 MJ/d 
(3260 kcal) for men and 9.5 MJ/d (2400 kcal) for women. 
The subjects in our trials underestimated their energy intake by about 10%. Mertz et al.2 
found an underreporting of 18% in a group of free-living volunteers when comparing 
energy intake recorded during a 7 days with energy intake needed to maintain body weight. 
Livingstone et al. 23 calculated the difference between self-reported energy intake and 
energy requirements as measured by the doubly labeled water method for 31 free-living 
men and women. They found an underestimation of 19% for men and of 18% for women 
23
. Hallfrisch et al.24 compared energy intake needed to maintain body weight in metabolic 
studies and found underestimations of 19% for the men and 37% for the women. Lissner 
et al. found 25 that women underestimated their energy intake by 24% when comparing self-
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reported energy intake by 3-5 day records with measured energy intake in a metabolic unit. 
Perhaps the high education level of the subjects in our study could be an explanation 
for the smaller underestimation observed here. Schoeller et al.26 reviewed three studies iA-21 
representing 79 non-athletic individuals from developed countries. These studies applied the 
doubly labeled water technique to determine actual energy requirements. Self-reported 
energy intake was on average 24% lower than determined energy need for men and 29% 
for women. However, obese subjects and adolescents were overrepresented in these studies, 
which could explain part of the large differences between reported and actual energy 
intake 27. In some other studies, reviewed by Black et al. ', the reported energy intake 
agreed with the energy requirements assessed by the doubly labeled water method, but the 
number of subjects was small. 
Subgroups and characteristics 
The women in our studies showed a larger relative degree of underreporting than the men. 
A gender-specific difference between reported and actual energy intake was also described 
by Schoeller et al. 26. They found the largest bias in men with low energy needs and in 
women with relatively high energy needs. At most we could confirm this for women, in 
whom we found a weak, non-significant positive association between the level of energy 
intake and the degree of underestimation. 
Underestimation is generally smaller in lean people than in obese 26. We could 
confirm this for the men but not for the women. However, few of our participants were 
obese. In our study the bias between reported and determined energy intake was similar for 
subjects older than 30 years and subjects 18-30 years of age. Still, age might affect the 
accuracy of food records. In adolescents differences between age groups have been 
reported '. Also, J(|>rgensen 28 reported that older age groups provided more complete 7-day 
food records than younger age groups. 
Conclusions 
Our study adds to the growing body of evidence that dietary records or surveys 
underestimate food intake. However, the precision of the method is high, as indicated by 
the high correlation between self-reported energy intake and actual energy need. Therefore 
records appear suitable for ranking well-educated, lean subjects by energy intake. However, 
for epidemiological studies and for assessing nutritional requirements of individuals one has 
to reckon with underestimation not only in obese but also in non-obese subjects. 
One way to improve the results of food records is an upward adjustment of the individual 
energy intakes with the mean expected underestimation of the group. The number of 
subjects classified within 5% of their actual energy need increased from 43 or 16% to 95 
or 35% when self-reported energy intakes were raised by 11%. However, one has to be 
cautious in adjusting individual food records because underreporting is not consistent among 
individuals. Although many suggestions have been made as to the causes of underestimation 
the characteristics of severe underreporters are still not clear. 
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General discussion 
104 Discussion 
We found that biological indicators of dietary intake and chemical analysis of food 
composites are appropriate methods to assess the intake of specific nutrients examined in 
the present research. Flavonols in plasma and urine can be used as biological indicators to 
distinguish between individuals with a low and with a high flavonol intake. A food 
frequency questionnaire and a 3-day food record are appropriate methods to classify 
subjects by their flavonol intake. However, to assess exposure of the body to flavonols, the 
intake of flavonols has to be corrected for the specific bioavailability of the foods 
consumed. This appears to be necessary because flavonol-rich foods such as tea, red wine, 
and onions differ in the bioavailability of flavonols. We also found that chemical analysis 
of food composites is an appropriate method to classify populations by intake of fatty acids 
and sterols. This method can be used to assess the intake both of much more specific fatty 
acids, such as trans or n-3 fatty acids, and of sterols than can be done by recall and record 
methods. Finally, we found that food records are not as accurate a method that as they are 
often considered to be. However, they are an appropriate method to categorize individuals 
by energy intake. 
Variation of flavonol intake in free-living subjects 
We used both a 1-day and 3-day food record and a food frequency questionnaire to assess 
variations in flavonol intake of free-living subjects (Chapter 3). We found differences in 
intake of up to 80 mg/day. 
The methods we used to assess flavonol intake had not been validated before. The 
3-day food record showed a large within-subject variation; therefore this method is probably 
not appropriate to assess the habitual flavonol intakes of individuals. However, the ratio of 
within- to between-subject variations was lower than one, which enables to study the 
relation between flavonol intake and disease. Moreover, flavonol intake determined by 
records correlated well with that determined by the food frequency questionnaire. Thus, the 
3-day food record and the food frequency questionnaire are appropriate to rank individuals 
by habitual flavonol intake and to estimate the mean flavonol intake of a group. 
The average flavonol intake of the subjects in our study was higher than that in 
epidemiological prospective studies 15. This could be due to a higher intake of flavonol-rich 
foods in our study. Also, the methods we used could have been more appropriate to assess 
flavonol intake than those used in the epidemiologic studies. For instance, the food 
frequency questionnaire was specially developed to estimate flavonol intake, and all 
important foods, also ready-to-eat foods containing onions, had been included. Thus, this 
method could have elicited reports of more foods contributing to flavonol intake. 
It would be worthwhile to develop this food frequency questionnaire further. This 
would require regular updates of the listed foods and additional analyses of the flavonol 
composition of foods. To convert intake data from the questionnaire into flavonol intakes, 
we used the flavonol contents of Dutch foods from Hertog et al6'7. They selected foods for 
flavonol analyses based on food intake data of the first Dutch National Food Consumption 
Survey performed in 1988 8. However, intake of foods has changed in the Netherlands since 
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that time. This was shown by the differences in intake between the first and the second 
Dutch National Food Consumption Survey performed in 1992 9. For instance, the intake of 
ready-to-eat foods increased by 32% in this period 9. Also, new foods important for flavonol 
intake, such as processed foods or new varieties of foods, have probably been included in 
the Dutch diet in this period. Thus, analysis of the flavonol composition of these foods is 
needed. After revision, the food frequency questionnaire should be validated in a larger 
population than in our study. 
Bioavailability of flavonols 
We found that the bioavailability of quercetin from tea was one-half of that from onions 
(Chapter 4 en 5), and bioavailability of quercetin from red wine was between that of onions 
and tea. We based these conclusions on the results of urinary excretions relative to the 
amount of quercetin consumed. These appear to reflect plasma levels 10. In previous studies 
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', we also found differences in absorption and bioavailability between different foods. 
Hollman suggested that the type of quercetin glycoside in foods plays a role 10 in 
absorption. Quercetin glucoside, the glycoside present in onions, would be better absorbed 
than quercetin rutinoside, present in tea. Similarly, the different types of quercetin 
glycosides present in red wine would result in an intermediate rate of absorption. In 
conclusion, the bioavailability of flavonols differs between the major dietary sources. 
Therefore, the intake of flavonols cannot be considered as a measure for flavonol exposure 
in the body n. Thus, flavonol intake has to be corrected for the bioavailability of the foods 
from which it is derived. 
The bioavailability of other major sources in the diet, mainly vegetables and fruit, 
are not known yet. Hollman 10 suggested estimating the bioavailability of flavonols in foods 
by determining the types of quercetin glycosides that they contain. When data of flavonol 
intake are corrected for bioavailability, outcomes of epidemiologic studies could be more 
consistent and probably better interpreted. For example, in some studies consumption of red 
wine was related to the occurrence of coronary heart disease, whereas in others it was not 
B
'
18
. Therefore, some researchers 19"21 suggested that consumption of red wine could explain 
the so-called French paradox: a high consumption of saturated fat intake in France while 
the occurrence of coronary heart disease is low. We showed (Chapter 4) that the 
bioavailability of flavonols from red wine, compared to that from other sources, was not 
high enough, to explain the French paradox by consumption of flavonols from red wine. 
Assessment of flavonol intake by biological indicators 
We found that levels of quercetin and kaempferol in plasma and urine were sensitive to 
their intakes from onions, tea and a diet of several flavonol-rich foods (Chapter 5 and 6). 
We also found that flavonol intake was related linearly to their levels in plasma and urine 
within the range of normal intake (Chapter 6). 
The use of flavonol markers is limited in practice because levels of flavonol in 
plasma or urine reflect only the intake of 3 or 4 days. This is a relative short period of 
intake for the purpose of most studies, for instance to investigate the relationship to chronic 
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disease. Therefore, measurements of flavonols in plasma or urine probably have to be 
repeated during a longer period. Further studies are required to determine how many of 
these measurements are needed and at what time intervals they have to be performed. 
The size of the measurement error of plasma quercetin allows individuals with a low 
flavonol intake to be distinguished from those with a high flavonol intake (Chapter 5 and 
6). However, we found a rather large difference in measurement error (about 30%) between 
our two studies. An important source of error is the between-subject variation in 
metabolism. The inconsistency between the two studies could be explained by differences 
in responsiveness to flavonols, dietary compliance, or smoking habits between subjects. In 
free-living subjects some additional factors such as age, disease, short-time effects of 
flavonol intake, and intake of drugs or supplements may increase the error. Thus, the use 
of plasma quercetin to assess quercetin intake appears to be promising. However, its 
variability has to be determined in free-living subjects to make the suitability of plasma 
quercetin as a biological indicator of quercetin intake clearer. 
We do not have sufficient information about the variability of plasma kaempferol 
and urinary quercetin and kaempferol to evaluate their utility. We do not have information 
about the actual variation in kaempferol intake between subjects, or about the variations of 
quercetin and kaempferol in urine within subjects. However, we expect that both plasma 
kaempferol and urinary quercetin and kaempferol will also be suitable to determine low and 
high flavonol intakes. This expectation is based on their sensitivity to intake and, for urinary 
markers, also on their reasonably high correlation with plasma flavonols. 
Flavonols are metabolized to a large extent. As long as they reflect intake, the extent 
of metabolism is not a problem for using flavonols as markers of flavonol intake. Quercetin 
in the body is partly metabolized to isorhamnetin, as was confirmed by the relationship 
between this flavonol and quercetin in our study (Chapter 6). However, the metabolism of 
flavonols is largely unknown. Therefore, it is not clear whether flavonols in plasma reflect 
flavonol status in the body and whether they could be directly related to the occurrence of 
disease. Finally, it may also be interesting to investigate whether a combination of flavonol 
markers, for example in a ratio, would improve prediction of intake. 
Assessment of the intake of fatty acids 
Sampling of food composites appeared to be a good method to use for categorizing 
populations by intake of fatty acids and sterols. We found clear differences in the 
consumption of total fat, specific fatty acids and sterols between the 16 cohorts. These data, 
which represent intakes of fatty acids and sterols in the Sixties, are useful to investigate the 
relationship of intake of these nutrients to the occurrence of disease in the Eighties and the 
Nineties. 
We sampled food composites 25 years after food records were sampled. In general, 
it is preferable to sample foods at the time that intake data are acquired, making it easier 
to obtain foods with the same composition as consumed. In the Sixties, duplicate portions 
of recorded food intakes were sampled, but not analyzed for specific nutrients such as trans 
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fatty acids and n-3 fatty acids. The health effects of these nutrients and methods for their 
chemical analysis only became known in the Eighties. Therefore, one of the most important 
prerequisites of our study was to sample foods with the same fat content as consumed 25 
years before. The high correlations between the fatty acid composition of the food 
composites in our study with that of duplicate portions collected in the Sixties confirmed 
that we succeeded in sampling similar foods. 
Another important prerequisite for sampling of food composites is that reported 
intakes have to be sufficiently accurate. The accuracy of food composites is ultimately as 
good as the food intake data on which they are based. For our study we needed intake data 
on the population level. The number of food records present for most cohorts was sufficient 
to meet this purpose. In addition, measurement error of the food records had to be similar 
for all cohorts to enable appropriate categorizing by their intake of fatty acids and sterols. 
In our study, we had some questions about the reports of the Belgrade cohort which 
included a higher amount of obese subjects reporting relatively lower energy intakes 22. For 
all other cohorts we could expect that measurement error of food records was similar. 
Sampling of food composites is not a suitable method to determine the intake of all 
nutrients. For example nutrients whose content in foods changes during storage or 
preparation cannot be determined accurately. The reason is that raw foods are sampled and 
that cooking practices are not taken into account. This is not a serious problem to determine 
fatty acids and sterols because they are rather stable. However, differences in cooking 
practices between cohorts, for example in preparing meat, could slightly have affected the 
results. In addition, it is only possible to determine nutrients for which a valid method for 
chemical analysis in foods is available. In our study we had to account for differences 
between trans fatty acids determined by gas chromatography and by Fourier transform 
infrared spectrometry. In general, the first method underestimates and the second method 
overestimates the content of trans fatty acids. We accounted for this when interpreting the 
results. 
Assessment of energy intake by food records 
On the average, young subjects underestimated energy intake reported by 3-day records by 
10% as compared with energy needs to maintain body weights (Chapter 2). The method in 
these subjects proved to be reasonably precise: the correlation coefficient between self-
reported energy intake and energy needs during the experiments was 0.70 for the men and 
0.73 for the women. 
The reference method in our study, energy needs during supervised feeding, can be 
regarded as an almost golden and independent standard because body weights of the 
subjects were stable 23,24, and because energy needs of the first two weeks of the experiment 
were not used for analyses. Because the subjects were non-obese, well-educated and 
motivated to provide good estimates, they could be expected to give the best possible 
reports 2 \ This was confirmed by the size of underestimation which was much smaller than 
in most other studies 23. Thus, in general it may be expected that self-reports by 3-day 
records will be underestimated by at least 10%. 
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Although a discrepancy of 10% is rather small, it may have consequences for the 
outcome of epidemiological studies. The reason is that underestimation of energy intake is 
not consistent in all subjects. In our study an underestimation of 10% affected only a small 
subset of the sample. This makes it difficult to estimate the actual energy intake of 
individuals. However, classification of subjects by their intake is possible because the 
method appeared to be reasonably precise. Thus, as long as the actual energy intake of 
individuals is not required, and the only purpose of the study is to investigate whether there 
is a relationship between the intake and the occurrence of disease, and not what the 
relationship is (Beaton, see also the introduction of this thesis), a 3-d food record will be 
an appropriate tool to determine energy intake in individuals. 
Conclusion 
In this thesis we evaluated methods to determine the intake of flavonoids, fatty acids, 
sterols, and energy for different purposes. It is clear that no one dietary assessment method 
suits all purposes. We found that quercetin in plasma is a biological indicator of flavonol 
intake and can be used to distinguish between subjects with a low and with a high intake. 
A food frequency questionnaire could also be used to classify subjects by their flavonol 
intake. Thus, the most feasible and accurate method to determine the intake of flavonoids 
in future epidemiological studies will probably be an adjusted and improved food frequency 
questionnaire validated in a substudy by levels of flavonols in plasma. To measure exposure 
of the body to flavonols, contents of flavonols in foods should be corrected for their 
bioavailability because bioavailability differs between the major sources in the diet. 
The bioavailability of quercetin from tea and red wine is respectively 50% and 75% of that 
from onions. In addition, we found that sampling of food composites was a successful 
method to distinguish the intake of more than forty fatty acids and sterols between 16 
cohorts in seven countries. Finally, we found that three-day food records underestimate 
energy intake at least by 10%, but that they can be applied successfully to categorize 
healthy adults by their energy intake. Thus, the goal of a study defines which dietary 
assessment method is to be selected. If the limitations of the methods are accounted for, 
assessment of dietary intake can be a successful enterprise. 
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Summary 
Diet is clearly related to the occurrence of disease. To investigate this relationship, it is 
important that dietary intake can be assessed accurately. Several methods are available to 
assess intake, but they all have their specific measurement errors. It is important to 
comprehend these errors, so the most appropriate method for the goal of the study can be 
selected. In view of this, common recall and record methods should not be selected to 
assess the intake of nutrients lacking accurate data in food composition tables. In addition, 
these methods are not appropriate to assess nutrients whose bioavailability differs between 
the most important sources in the diet. For these nutrients, such as flavonoids, minor fatty 
acids and plant sterols, a biological marker of intake or chemical analysis of food 
composites could be a more appropriate method of measurement. In this thesis, we focused 
on physically and chemically based methods to assess the intake of flavonoids, fatty acids, 
sterols and energy. 
Flavonols and flavones are a subgroup of the flavonoids. Quercetin and kaempferol 
are main representatives of the flavonols. Several studies showed that flavonoids are 
inversely related to the occurrence of coronary heart disease. However, other studies 
showed no relationship. One reason for this inconsistency could be that the assessment of 
flavonoid intake was too imprecise. Therefore, we investigated how the intake of 
flavonoids, especially of flavonols, could be assessed accurately. 
We first investigated the average intake of flavonols and flavones in the diet of two 
groups of free-living subjects by using food records and a food frequency questionnaire 
(Chapter 2). One group consisted of thirteen non-resident aliens and four Dutch volunteers 
who all ate a wide variety of diets. The other group consisted of eight Dutch volunteers 
who ate normal Dutch diets. We found marked differences of up to 80 mg/day in flavonol 
and flavone intake between these subjects. The variation of intake of these flavonoids 
within subjects was relatively small compared to variations between subjects, giving a fine 
opportunity to study the relation between flavonoids and health. However, the within-
subject variation indicated that food had to be recorded for 38 days to assess individual 
habitual flavonoid intake; results of 3-day food records are probably not representative of 
habitual intake. The food frequency questionnaire seems to be more suitable, because it 
reflects a period of 30 days of intake. Nevertheless, the results of this method correlated 
well with those derived by the 3-day food records. Thus, both methods may be suitable to 
classify subjects by flavonoid intake. 
We also investigated whether it was necessary to account for the bioavailability of 
flavonols from different flavonol-rich foods (Chapter 3). In a first study, we compared the 
bioavailability of the intake of 15 mg of quercetin from red wine, black tea, and fried 
onions. Concentrations of quercetin in plasma and excretions in urine after wine were 
significantly higher than after baseline. The bioavailability of quercetin from red wine was 
75% of that from onions and that of tea 50% of that from onions. Consumption of one glass 
of wine with an average quercetin content would produce plasma quercetin levels similar 
to those after consumption of half a cup of average tea or 5 grams of onions. Therefore, the 
intake of bioavailable flavonols from wine is quite modest and cannot explain the so-called 
French paradox: the difference in coronary heart disease between France and other western 
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countries. We concluded that red wine is a poor source of bioavailable flavonols compared 
to tea and onions. In a following study, described in Chapter 4, it was confirmed that the 
bioavailability of quercetin from tea was smaller than that from onions. In this study, we 
fed 15 volunteers tea or onions and then measured both concentrations of quercetin and 
kaempferol in plasma and excretions of these flavonols in urine. Similar to quercetin, 
kaempferol from tea was also absorbed. 
We also examined whether levels of flavonols in plasma and urine may be used as 
biomarkers of intake. To that end, we repeated the treatment with onions to measure the 
within-subject variation of quercetin in plasma and urine. This variation has to be relatively 
small compared to the between-subject variation of flavonol intake in free-living subjects. 
We found ratios of the within-subject to the between-subject components of variance of 
lower than one. Therefore, we concluded that concentrations of quercetin in plasma and its 
excretions in urine can be used in epidemiological studies as biomarkers to measure intake. 
In a subsequent study (Chapter 5), we further investigated the suitability of flavonols 
in plasma and urine as biomarkers of dietary intake. In that study, we measured flavonols 
in plasma and urine after a high dose of flavonols consumed by nine subjects during four 
weeks. In addition, we combined the results with those of the studies described in Chapter 
3 and Chapter 4. The intake of flavonols appears to be related linearly to their 
concentrations in plasma and excretions in urine. Moreover, the variability of quercetin in 
plasma allows its use as a biological marker to distinguish individuals with a low or with 
a high intake of quercetin. We did not have enough data on the variability of urinary 
quercetin, plasma kaempferol, or urinary kaempferol to draw conclusions about their utility 
as biomarkers. 
In another study, we assessed the intake of fatty acids and sterols of middle-aged 
men living in 16 cohorts in seven countries (Chapter 6). The objective of this study was to 
obtain detailed information on the fatty acid and plant sterol composition of the diets. 
Therefore, we determined the mean content of 42 fatty acids and four sterols in food 
composites. Foods for these composites were collected in the regions where the men lived 
in the Sixties. Chemical analyses of the composites were performed in a central laboratory. 
We found large differences in the amounts of total fat, fatty acids, and sterols between the 
seven countries and also between cohorts in the same country. These differences reflected 
the variations in food consumption patterns. The results of these chemical analyses can be 
used to investigate relationships between the composition of diets in the 1960s and the 
occurrence of disease in later years. We concluded that assessing fatty acids and sterols in 
diets by chemical analysis of equivalent food composite portions is an adequate tool to 
estimate the average intake of subsamples of populations. This method allows assessment 
of more fatty acids and sterols than do methods needing food tables. 
Finally, we also investigated the accuracy of food records to assess energy intake 
(Chapter 7). To that end, we compared self-reported energy intake, calculated from 3-day 
records of 269 adults, with actual energy intake needed to maintain body weight during 
controlled trials. The subjects were young, non-obese, and highly educated adults, and could 
therefore be expected to provide valid estimations of their energy intake. The consumption 
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of diets with known energy contents was supervised. This provided us with an almost 
"golden standard" for determining energy intake. On the average the subjects in our study 
underestimated their energy requirements by 10%. Although a self-reported energy intake 
of 10% less than actual energy intake seems small, the consequences for the interpretation 
of nutritional survey data are substantial. The method proved to be reasonably precise, as 
indicated by the correlation coefficient of 0.70 between reported and actual energy intake 
for men as well as for women. Thus, a 3-day food record can be used to classify subjects 
by their energy intake, but it is not an appropriate method to assess individual energy 
intake. 
Studies described in this thesis show that biological markers of intake or chemical 
analysis of food composites can be good tools to assess nutrients lacking in food 
composition tables. Also, biological markers of intake can be good tools to assess nutrients 
whose bioavailability differs between the most important dietary sources. By these methods 
the intake of flavonoids, fatty acids, and sterols can be measured successfully within certain 
limitations. In addition, a food frequency questionnaire specially devised to measure 
flavonoid intake and validated by biomarkers of intake appears to be a feasible method to 
assess the intake of flavonoids in epidemiological studies. However, when using food 
records even from lean, well-educated adults underestimation of intakes has to be taken into 
account. The conclusion of this thesis is that the intake of flavonoids, fatty acids, sterols 
and energy can be assessed successfully if the method is selected carefully in regard to the 
specific properties of these food components and the aim of the study. 
Samenvatting 
Voeding speelt een belangrijke rol bij het ontstaan van ziekten. Om de relatie tussen 
voeding en ziekten te kunnen onderzoeken is het belangrijk dat de inneming van voedsel 
nauwkeurig kan worden vastgesteld. Verschillende methoden zijn beschikbaar om de 
inneming te bepalen, maar alien hebben specifieke meetfouten. Het is belangrijk om deze 
fouten te kennen, zodat er in onderzoeksontwerp en interpretatie van resultaten rekening 
mee kan worden gehouden. In het onderzoeksontwerp zal men zorgvuldig de meest 
geschikte methode voor het doel van de studie moeten kiezen. Zo kunnen de gewone 
opschrijf- en navraagmethoden beter niet worden gekozen om de inneming van 
voedingsstoffen vast te stellen, waarvan geen gegevens in voedingsmiddelentabellen 
beschikbaar zijn. Ook zijn deze methoden minder geschikt voor het vaststellen van 
voedingsstoffen, waarvoor de biobeschikbaarheid tussen voedingsmiddelen verschillend of 
niet bekend is. Voor deze voedingsstoffen zou een biologische merker of chemische analyse 
van 24-uursvoedingen een geschiktere methode kunnen zijn. Voorbeelden van dit soort 
voedingsstoffen zijn flavonoiden, specifieke vetzuren en plantensterolen. In dit proefschrift 
richtten we ons met name op het vaststellen van de inneming van deze voedingsstoffen. 
Ook onderzochten we of met de drie-daagse opschrijfmethode de energie-inneming 
nauwkeurig kan worden vastgesteld. 
Flavonolen en flavonen zijn subgroepen van de flavonoiden. Quercetine en 
kaempferol zijn de belangrijkste vertegenwoordigers van de flavonolen. Uit verschillende 
studies kwam naar voren dat flavonolen en flavonen een inverse relatie met het voorkomen 
van hart-en vaatziekten hebben. Echter in sommige studies kon geen verband worden 
aangetoond. Een mogelijke reden zou kunnen zijn dat de inneming van flavonoiden niet 
nauwkeurig genoeg kon worden vastgesteld. Daarom onderzochten we methoden om de 
inneming van flavonoiden, en met name van flavonolen, in de voeding te bepalen. 
Eerst onderzochten we de gemiddelde inneming van flavonolen en flavonen in de 
voeding van twee groepen "vrijlevende" personen met behulp van de opschrijf- en 
voedselfrequentiemethoden (Hoofdstuk 2). Een groep bestond uit 13 buitenlandse en vier 
Nederlandse deelnemers met een zeer gevarieerd voedingspatroon. De andere groep bestond 
uit acht Nederlandse vrijwilligers met een normale Nederlandse voeding. We vonden 
verschillen in inneming van flavonolen en flavonen tussen deze deelnemers tot 80 mg per 
dag. Deze verschillen waren groter dan die gevonden werden in epidemiologische studies. 
De binnen-persoonsvariatie in de inneming van deze flavonoiden was klein, in verhouding 
tot de tussenpersoonsvariatie. Hieruit blijkt dat de spreiding tussen personen groot genoeg 
is om de relatie van flavonoideninneming met het ontstaan van ziekten te bestuderen. Uit 
de binnenpersoonsvariatie kon berekend worden dat voor het vaststellen van de individuele 
flavonoideninneming de voeding ongeveer 38 dagen moet worden genoteerd. De drie-
daagse opschrijfmethode lijkt hiervoor dus niet geschikt. De referentieperiode van de 
voedselfrequentielijst was echter 30 dagen. Niettemin vonden we een goede relatie tussen 
de uitkomsten van de voedselfrequentelijst en die van de drie-daagse opschrijfmethode. 
Daarom lijken beide methoden geschikt om personen te classificeren naar hun 
flavonoideninneming. Om te onderzoek of de voedselfrequentielijst ook geschikt is om de 
individuele flavonoideninneming vast te stellen zal deze echter eerst in een grotere groep 
116 Samenvatting 
deelnemers moeten worden gevalideerd. 
Ook onderzochten we of het nodig was om rekening te houden met verschillen in 
biobeschikbaarheid van flavonolen tussen de bronnen in de voeding. In een eerste studie 
vergeleken we de biobeschikbaarheid van de inneming van 15 mg quercetine tussen rode 
wijn, zwarte thee en gebakken uien (Hoofdstuk 3). Concentraties van quercetine in plasma 
en uitscheiding in de urine na consumptie van rode wijn bleken significant hoger dan de 
basiswaarden. De biobeschikbaarheid van quercetine uit rode wijn was echter 75% en uit 
thee 50% van die uit uien. De consumptie van een glas rode wijn met een gemiddelde 
hoeveelheid quercetine zou in quercetinegehalten in plasma resulteren, die hetzelfde zijn als 
na een halve kop thee of na vijf gram uien. Daarom is de hoeveelheid flavonolen in rode 
wijn, beschikbaar voor het lichaam, vrij beperkt. Flavonolinneming uit rode wijn kan 
daarom niet de Franse paradox, het verschil in hart- en vaatziekten tussen Frankrijk en 
andere landen, verklaren. We concludeerden dan ook dat rode wijn in vergelijking met thee 
en uien een slechte bron is van flavonolen voor het lichaam. In een tweede studie naar 
biobeschikbaarheid, beschreven in Hoofdstuk 4, werd de slechtere beschikbaarheid van 
flavonolen uit thee bevestigd. In deze studie, bepaalden we concentraties van quercetine en 
kaempferol in plasma en de uitscheiding van deze flavonolen in de urine van 15 
vrijwilligers die uien of thee kregen. Behalve quercetine, bleek ook kaempferol uit thee te 
worden geabsorbeerd. Een ander doel van deze studie was om te onderzoeken of flavonolen 
in plasma en urine kunnen worden gebruikt als biologische merkers voor hun inneming. 
Daartoe gaven we dezelfde hoeveelheid uien twee keer teneinde de binnen-persoonsvariatie 
van quercetine in plasma en urine vast te stellen. Op basis van de gevonden variaties 
concludeerden we dat concentraties van quercetine in plasma en de uitscheiding van deze 
stof in urine gebruikt kunnen worden om de inneming in epidemiologische studies te 
bepalen. 
We onderzochten de geschiktheid van flavonolen in plasma en urine als biologische 
merkers voor de inneming verder in een volgende studie (Hoofdstuk 5). In deze studie, 
bepaalden we flavonolen in plasma en urine na een hoge dosis flavonolen ingenomen door 
negen proefpersonen gedurende vier weken. Daarna combineerden we de uitkomsten van 
deze studie met die van twee andere studies, beschreven in Hoofdstuk 3 en 4. Er bleek een 
lineair verband te bestaan tussen de inneming van flavonolen met de concentraties van deze 
stoffen in plasma en hun uitscheiding in de urine. Ook bleek dat de variabiliteit van 
quercetine in plasma het mogelijk maakt om deze concentraties te gebruiken om 
onderscheid te maken tussen personen met een lage en hoge inneming. We hadden niet 
genoeg gegevens over de variabiliteit van quercetine in urine en van kaempferol in plasma 
en urine om ook hun bruikbaarheid als biologische merker vast te stellen. 
In een andere studie onderzochten we in hoeverre het verschil in inneming van 
vetzuren en sterolen tussen mannen afkomstig uit 16 regio's kon worden bepaald met 
behulp van directe analyse van 24-uursvoedingen. Om hierover gedetailleerde informatie 
te krijgen bepaalden we de gemiddelde samenstelling van 42 vetzuren en vier sterolen in 
deze 24-uursvoedingen. We verzamelden de voedingsmiddelen hiervoor in de 16 regio's 
verdeeld over zeven landen waar de mannen in de jaren 60 woonden. De samengestelde 24-
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uursvoedingen werden in een centraal laboratorium geanalyseerd. We vonden grote 
verschillen in de hoeveelheid totaal vet, vetzuren en sterolen tussen de 7 landen en ook 
tussen de cohorten in hetzelfde land. Deze verschillen gaven een goede afspiegeling van het 
verschil in voedingspatroon. De resultaten van deze chemische analyses kunnen worden 
gebruikt om de relaties tussen de samenstelling van de voedingen in de jaren 60 en het 
ontstaan van ziekten in latere jaren te onderzoeken. We concludeerden dat het vaststellen 
van vetzuren en sterolen in de voedingen door chemische analyse van 24-uursvoedingen een 
geschikte methode is om de gemiddelde inneming van subgroepen in de populatie vast te 
stellen. Met deze methode kunnen meer vetzuren en sterolen worden vastgesteld dan met 
het gebruik van voedingsmiddelentabellen. Tenslotte onderzochten we de nauwkeurigheid 
van de drie-daagse opschrijfmethode voor het vaststellen van de energie-inneming. Daartoe 
vergeleken we de energie-inneming volgens de drie-daagse opschrijfmethode gerapporteerd 
door 269 deelnemers met hun energiebehoefte tijdens gecontroleerde voedingsproeven. Hun 
lichaamsgewicht werd daarbij constant gehouden. De deelnemers waren jong, niet-obees en 
hoog-opgeleid. Daarom mocht worden verwacht dat ze nauwkeurig zouden rapporteren. De 
verstrekkingen van de voedingen tijdens de proeven werden goed gecontroleerd. We 
beschikten daardoor over een bijna gouden standaard om de energie-inneming vast te 
stellen. De deelnemers bleken hun energie-inneming gemiddeld 10% te onderschatten. 
Hoewel een onderschatting van 10% niet veel is, lijkt de consequentie voor de interpretatie 
van uitkomsten van voedingsonderzoek substantieel. De precisie van de methode bleek 
redelijk goed te zijn, zoals bleek uit de correlatie van 0.70 tussen gerapporteerde en 
werkelijke energie-inneming zowel voor mannen als voor vrouwen. Daarom lijkt de drie-
daagse opschrijfmethode geschikt om deelnemers te classificeren naar inneming, maar niet 
om de werkelijke inneming van individuen te schatten. 
De studies over de inneming van voedingsstoffen beschreven in dit proefschrift 
tonen aan dat biologische merkers voor het vaststellen van de inneming en chemische 
analyse van 24-uursvoedingen goede methoden kunnen zijn voor het vaststellen van 
voedingsstoffen, die niet opgenomen zijn in voedingsmiddelentabellen. Biologisch merkers 
kunnen ook een goede methode zijn voor het vaststellen van voedingsstoffen voor welke 
de biobeschikbaarheid tussen verschillende voedingsmiddelen verschilt. Deze methoden 
blijken geschikt om de inneming van flavonoi'den, vetzuren en sterolen te meten. Daarnaast 
zou ook een voedselfrequentielijst een goede methode kunnen zijn om de inneming van 
flavono'iden vast te stellen. De drie-daagse opschrijfmethode bleek echter niet zo 
nauwkeurig als vaak wel wordt gedacht. De resultaten toonden aan dat zelfs een groep niet-
dikke, goed-opgeleide deelnemers hun energie-inneming met 10% onderschatten. Deze 
methode is daarom niet geschikt om de individuele energie-inneming vast te stellen, maar 
wel om personen te classificeren naar hun energie-inneming. De conclusie van dit 
proefschrift is dat de inneming van flavonoi'den, vetzuren, sterolen en energie met succes 
kan worden vastgesteld. De methoden moeten echter zorgvuldig worden gekozen met 
betrekking tot de specifieke eigenschappen van deze voedselcomponenten en het doel van 
het onderzoek. 
Dankwoord 
Al bijna twintig jaar ben ik werkzaam op de vakgroep Humane Voeding, de huidige 
afdeling Humane Voeding en Epidemiologie. Als dietist heb ik aan verschillende 
onderzoeken meegewerkt waarop OIO's en AIO's zijn gepromoveerd. In die tijd kwam de 
vraag wel eens bij me op of ik het wetenschappelijke gedeelte van het onderzoek ook tot 
een goed einde zou kunnen brengen. Dat leek me wel een uitdaging. Daarom was ik 
aangenaam verrast toen Martijn Katan me bijna vijf jaar geleden vroeg of promoveren niet 
iets voor mij zou zijn. De ambitie had ik wel, maar ik had intussen ook gezien dat je 
promoveren er niet zo maar even bij kon doen. Met drie kleine kinderen thuis had ik 
daarom wel wat aarzelingen. Maar ik kreeg gelukkig de kans rustig aan te beginnen en 
langzaam alle kneepjes van het vak te leren kennen. 
Daarom wil ik allereerst mijn promoter Martijn Katan bedanken voor dit initiatief 
en voor de kans die hij mij hiermee bood. Martijn, we hebben al in heel wat 
voedingsproeven samengewerkt en ik heb daar goede herinneringen aan. Je enthousiasme 
voor het onderzoek bracht je aan ons, je medewerkers over, en je liet ons delen in de 
waardering die er in de wetenschappelijke wereld voor was. Tijdens mijn promotie-
onderzoek was je een ware leermeester voor mij. Ten tweede wil ik Wija van Staveren, 
mijn andere promotor, bedanken. Met Wija was ik niet alleen verzekerd van deskundige 
begeleiding op het gebied van voedselconsumptie-onderzoek, maar ook van warme 
persoonlijke ondersteuning. Wija, ik denk nog altijd met plezier terug aan ons gezellige 
verblijf in Boston en Washington, waar je me introduceerde bij diverse onderzoekers en 
waar we samen verschillende bezienswaardigheden bezochten. Professor Hautvast wil ik 
hartelijk bedanken voor zijn bijdragen in mijn begeleidingscommissie en ook voor zijn 
interesse in mijn wel en wee buiten het onderzoek om. 
Een van de belangrijkste personen tijdens mijn promotie-onderzoek was Peter 
Hollman. Zonder zijn analyses zouden vier van mijn artikelen niet zijn opgeschreven. Peter, 
we hadden binnen de uitvoering van het flavonoi'denproject een mooie complementaire en 
prettige samenwerking. Daarnaast heb ik je originele kritische opmerkingen ten aanzien van 
mijn onderzoek steeds zeer op prijs gesteld. Michel Buysman en de andere medewerkers 
op Peter's laboratorium wil ik bedanken voor alle analyses die ze voor mijn onderzoek 
gedaan hebben. 
Er bestaan gelukkig nog steeds mensen die geheel belangeloos klaar staan om 
anderen te helpen. Gedurende mijn promotie-onderzoek waren dat met name Karin Jansen, 
Margreet Olthof, Monique Maas en Peter Zock. Karin, jij hebt me wegwijs gemaakt op het 
lab en kwam mij te hulp bij mijn Flavo4-onderzoek, terwijl je het zelf druk had met je 
eigen promotie-onderzoek. Margreet, jij hebt ontzettend veel werk verzet in het rode-wijn-
onderzoek en door je nieuwe ideeen was het inspirerend om met je samen te werken. 
Monique, jij hebt ons prima geholpen met de rode-wijnproef en je bleef steeds vriendelijk 
ook al kostte het werk je meer tijd dan je verwachtte. Peter, jij hebt me geweldig geholpen 
met de lastige statistiek en je was altijd bereid om tussendoor een manuscript na te kijken. 
Ook mijn "eigen" groep, de dietisten, wil ik bedanken. Samen met Saskia Meyboom 
heb ik tijdens dit onderzoek kilo's uien geschild en liters thee gezet. Saskia, je bent een 
prettige collega en kamergenoot. Ik stel het op prijs dat jij mij tijdens de 
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promotieplechtigheid wilt ondersteunen. Al sinds ik op de vakgroep begon werk ik samen 
met Ypie Blauw, Lidwien van der Heyden, en toegevoegd "dietist" Hannie van Oosten. 
Ypie, Lidwien en Hannie, ik bof met zulke fijne collega's. Ik wil jullie bedanken voor de 
gezellige lunches en het meeleven met drukte random mijn onderzoek en mijn gezin. Karin 
Roosemalen en Els Siebelink, jullie wil ik bedanken voor de rust die jullie met Saskia 
creeerden op kamer 221, zodat ik er prima kon schrijven. 
Vervolgens wil ik vier co-auteurs van artikelen bedanken voor hun belangrijke 
bijdragen. Dankzij Daan Kromhout en Annemarie Jansen had ik voldoende gegevens en 
achtergrondinformatie om het artikel over de vetzuurinneming in de 7-landenstudie op te 
kunnen schrijven. Ronald Mensink voorzag me van kritische opmerkingen vol humor; ze 
waren voor mij een plezier om te lezen. Peter van de Bovenkamp heeft mij met veel geduld 
deskundig uitleg gegeven over de chemische analyses van vetzuren. 
Het tijdstip voor de bloedafnamen tijdens mijn proeven was niet altijd ruim van te 
voren bekend. Gelukkig kon er desondanks op het laboratorium toch steeds wat geregeld 
worden. Dat was dankzij de flexibele inzet van Joke Barendse, Jan Harryvan, Robert 
Hovenier, Paul Hulshof en Marga van der Steen. Ik wil julie daarvoor nogmaals bedanken. 
Mijn deskundigheid op bepaalde terreinen schoot wel eens tekort. Gelukkig kon ik 
een beroep doen op Jan Burema voor hulp bij de statistiek, Susan Parren voor correctie van 
het Engels en Ben Scholte en zijn team voor ondersteuning op computergebied. Ik wil jullie 
daar hartelijk voor bedanken. 
Vier studenten waren bij de uitvoering van mijn onderzoek betrokken: Hanneke 
Schippers en Thomas Vollman hebben met veel enthousiasme Flavo7 helpen uitvoeren en 
Ingrid van Amersfoort en Margje Hylkema hebben erg hard mee gewerkt aan het rode-
wijnonderzoek. 
Ook de proefpersonen ben ik zeer dankbaar. Ze hadden het niet altijd gemakkelijk 
met onze niet zo evenwichtige dieten. Ondanks dat ze verplicht waren veel uien, sterke thee 
en rode wijn te consumeren hebben ze echter weinig geklaagd. 
Ik was nooit een echte AIO, niet qua aanstelling en niet qua leeftijd, maar 
desondanks heb ik me altijd welkom gevoeld binnen de AlO-club. Ik wil alle AIO's voor 
deze hartelijkheid en hun meeleven bedanken. 
Nel van Mierlo is al sinds het begin van de dietistenopleiding een heel goede 
vriendin en heeft met veel enthousiasme het mooie omslag van mijn boekje gemaakt. Nel, 
dank je wel daarvoor. 
Ook mijn familie wil ik bedanken. Mijn moeder wil ik bedanken voor haar goede 
zorgen. 6 februari is niet alleen vanwege mijn promotie een gedenkwaardige dag, maar ook 
omdat zij dan 70 jaar wordt. Mijn broers, zussen, overige familie en ook vrienden wil ik 
bedanken voor hun meeleven en het begrip dat ze toonden als ik het vanwege drukte af liet 
weten. Mijn zus Ria is mijn andere paranimf. Ria, ik waardeer het zeer dat jij je vanaf het 
begin zo voor mijn onderzoek hebt gei'nteresseerd. 
Veel mensen hebben me gedurende de afgelopen vier jaren gevraagd hoe ik het 
redde om een gezin, werk en promotie-onderzoek te combineren. Een van de belangrijkste 
antwoorden daarop ben jij, Norbert. Jij wist dat ik dit onderzoek graag wilde doen en je 
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hebt je er volledig voor ingezet. Jij bent een van de weinige mannen die ondanks 
maatschappelijke tegenwerking een evenredig deel van de verzorging voor de kinderen, het 
huishouden en het werk op zich neemt en als het nodig is zelfs wat meer. Niels en Vera, 
jullie hebben er al heel bewust regelmatig voor gezorgd dat ik rustig kon werken en Iris, 
jij krijgt eindelijk je mooie jurk, want: beloofd is beloofd. 
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